Atlas Financial (AFHIF) 10-Q 30 Mar 20 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2019
Document and Entity Information [Abstract]
Entity registrant name	Atlas Financial Holdings, Inc.
Entity central index key	0001539894
Current fiscal year end date	--12-31
Entity filer category	Accelerated Filer
Document type	10-Q
Document period end date	Sep. 30, 2019
Document fiscal year focus	2019
Document fiscal period focus	Q3
Amendment flag	false
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Common stock, shares outstanding (in shares)		11,942,812

Condensed Consolidated Statemen

Condensed Consolidated Statements of Financial Position - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Investments
Fixed income securities, available for sale, at fair value (amortized cost $77,424 and $133,213)	$ 78,363	$ 129,991
Equity securities, at fair value (cost $0 and $5,650)	1	5,929
Short-term investments, at cost	8,562	4,745
Other investments	19,461	25,043
Total investments	106,387	165,708
Cash and cash equivalents	54,008	34,902
Accrued investment income	455	749
Premiums receivable (net of allowance of $6,454 and $5,115)	68,609	88,596
Reinsurance recoverables on amounts paid	9,383	12,388
Reinsurance recoverables on amounts unpaid	79,105	68,771
Prepaid reinsurance premiums	42,615	36,898
Deferred policy acquisition costs	4,815	7,309
Intangible assets, net	3,462	3,755
Property and equipment, net	30,730	31,363
Other assets	11,099	19,899
Total assets	410,668	470,338
Liabilities
Claims liabilities	243,966	273,496
Unearned premium reserves	111,936	134,040
Due to reinsurers	9,183	15,849
Notes payable, net	24,423	24,255
Other liabilities and accrued expenses	16,810	16,999
Total liabilities	406,318	464,639
Commitments and contingencies
Shareholders' Equity
Ordinary voting common shares, $0.003 par value, 266,666,667 shares authorized, shares issued: September 30, 2019 - 12,198,319 and December 31, 2018 - 12,192,475; shares outstanding: September 30, 2019 - 11,942,812 and December 31, 2018 - 11,936,970	36	36
Restricted voting common shares, $0.003 par value, 33,333,334 shares authorized, shares issued and outstanding: September 30, 2019 and December 31, 2018 - 0	0	0
Additional paid-in capital	202,983	202,298
Treasury stock, at cost: 255,505 shares of ordinary common voting shares at September 30, 2019 and December 31, 2018, respectively	(3,000)	(3,000)
Retained deficit	(196,697)	(190,503)
Accumulated other comprehensive income (loss), net of tax	1,028	(3,132)
Total shareholders' equity	4,350	5,699
Total liabilities and shareholders' equity	$ 410,668	$ 470,338

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Financial Position (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Statement [Line Items]
Fixed income securities at fair value, amortized cost	$ 77,424	$ 133,213
Equity securities, at fair value, cost	0	5,650
Premiums receivable, allowance	$ 6,454	$ 5,115
Shareholders' Equity
Common stock, shares authorized (in shares)	300,000,001
Common stock, shares issued (in shares)	12,198,319	12,192,475
Common stock, shares outstanding (in shares)	11,942,812	11,936,970
Treasury stock, common stock, shares held (in shares)	255,505	255,505
Ordinary Voting Common Shares
Shareholders' Equity
Common stock, par value (USD per share)	$ 0.003	$ 0.003
Common stock, shares authorized (in shares)	266,666,667	266,666,667
Common stock, shares issued (in shares)	12,198,319	12,192,475
Common stock, shares outstanding (in shares)	11,942,812	11,936,970
Restricted Voting Common Shares
Shareholders' Equity
Common stock, par value (USD per share)	$ 0.003	$ 0.003
Common stock, shares authorized (in shares)	33,333,334	33,333,334
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

Condensed Consolidated Statem_3

Condensed Consolidated Statements of (Loss) Income and Comprehensive Income (Loss) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Net premiums earned	$ 40,582,000	$ 54,461,000	$ 131,872,000	$ 165,712,000
Net investment income	428,000	1,070,000	2,280,000	3,201,000
Loss from change in fair value of equity securities	(3,000)	(2,000)	(277,000)	(97,000)
Net realized gains	411,000	54,000	1,091,000	501,000
Other income	128,000	186,000	721,000	366,000
Total revenue	41,546,000	55,769,000	135,687,000	169,683,000
Net claims incurred	28,841,000	33,542,000	96,467,000	102,397,000
Acquisition costs	3,248,000	5,701,000	9,960,000	18,357,000
Other underwriting expenses	11,099,000	8,841,000	33,719,000	26,762,000
Amortization of intangible assets	98,000	97,000	293,000	292,000
Interest expense	476,000	465,000	1,416,000	1,381,000
Expenses recovered pursuant to stock purchase agreements	0	0	0	(520,000)
Total expenses	43,762,000	48,646,000	141,855,000	148,669,000
(Loss) income from operations before income taxes	(2,216,000)	7,123,000	(6,168,000)	21,014,000
Income tax expense	26,000	1,518,000	26,000	4,304,000
Net (loss) income	$ (2,242,000)	$ 5,605,000	$ (6,194,000)	$ 16,710,000
Basic weighted average common shares outstanding (in shares)	11,954,494	11,936,970	11,954,494	12,014,817
Earnings per common share basic (in dollars per share)	$ (0.19)	$ 0.47	$ (0.52)	$ 1.39
Diluted weighted average common shares outstanding (in shares)	11,954,494	11,951,217	11,954,494	12,031,738
Earnings per common share diluted (in dollars per share)	$ (0.19)	$ 0.47	$ (0.52)	$ 1.39
Condensed Consolidated Statements of Comprehensive Income (Loss)
Net (loss) income	$ (2,242,000)	$ 5,605,000	$ (6,194,000)	$ 16,710,000
Other comprehensive income (loss:)
Changes in net unrealized investment (losses) gains	(195,000)	(307,000)	2,243,000	(4,008,000)
Reclassification to net income	541,000	(19,000)	1,917,000	191,000
Effect of income taxes	0	69,000	0	802,000
Other comprehensive income (loss)	346,000	(257,000)	4,160,000	(3,015,000)
Total comprehensive (loss) income	$ (1,896,000)	$ 5,348,000	$ (2,034,000)	$ 13,695,000

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Ordinary Voting Common Shares	Restricted Voting Common Shares	Additional Paid-In Capital	Treasury Stock	Retained Deficit	Accumulated Other Comprehensive Income/(Loss)
Balance at beginning of period at Dec. 31, 2017	$ 90,645	$ 36	$ 0	$ 201,105	$ 0	$ (110,535)	$ 39
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	16,710					16,710
Repurchase of common shares	(3,000)				(3,000)
Preferred dividends paid	(333)					(333)
Other comprehensive income (loss)	(3,015)						(3,015)
Share-based compensation	856			856
Adjustments to additional paid in capital, other	(8)			(8)
Balance at end of period at Sep. 30, 2018	101,855	36	0	201,953	(3,000)	(93,781)	(3,353)
Balance at beginning of period at Dec. 31, 2018	5,699	36	0	202,298	(3,000)	(190,503)	(3,132)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(6,194)					(6,194)
Other comprehensive income (loss)	4,160						4,160
Share-based compensation	685			685
Balance at end of period at Sep. 30, 2019	$ 4,350	$ 36	$ 0	$ 202,983	$ (3,000)	$ (196,697)	$ 1,028

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Operating activities:
Net (loss) income	$ (2,242)	$ 5,605	$ (6,194)	$ 16,710
Adjustments to reconcile net income to net cash flows used in operating activities:
Depreciation and amortization	1,202	696	3,387	2,061	$ 2,900
Share-based compensation expense			685	856
Amortization of intangible assets	98	97	293	292
Deferred income taxes			0	4,745
Loss from change in fair value of equity securities	3	2	277	97
Net realized gains	(411)	(54)	(1,091)	(501)
Gain in equity of investees			(552)	(838)
Amortization of bond premiums and discounts			303	518
Amortization of financing costs			168	168
Net changes in operating assets and liabilities:
Accrued investment income			294	144
Premiums receivable, net			19,987	(21,697)
Due from reinsurers and prepaid reinsurance premiums			(13,045)	(25,282)
Deferred policy acquisition costs			2,494	4,403
Other assets			8,800	(559)
Claims liabilities			(29,530)	(24,667)
Unearned premium reserves			(22,104)	21,320
Due to reinsurers			(6,666)	10,742
Other liabilities and accrued expenses			(190)	(109)
Net cash flows used in operating activities			(42,684)	(11,597)
Purchases of:
Fixed income securities			(11,506)	(33,989)
Equity securities			0	(2,350)
Other investments			(680)	(1,161)
Short-term investments			(12,937)	(4,620)
Property and equipment			(2,783)	(7,950)
Proceeds from sale and maturity of:
Fixed income securities			67,189	59,442
Equity securities			5,997	5,373
Other investments			7,390	3,829
Short-term investments			9,120	0
Net cash flows provided by investing activities			61,790	18,574
Financing activities:
Purchase of treasury stock			0	(3,000)
Preferred dividends paid			0	(333)
Other			0	(8)
Net cash flows provided by (used in) financing activities			0	(3,341)
Increase in cash position			19,106	3,636
Cash position, beginning of period			34,902	45,615	45,615
Cash position, end of period	$ 54,008	$ 49,251	54,008	49,251	$ 34,902
Supplemental disclosure of cash information:
Cash (recovered) paid for income taxes			(14,349)	(1,724)
Cash (recovered) paid for interest			$ 1,242	$ 1,242

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Basis of Presentation	Nature of Operations and Basis of Presentation Atlas Financial Holdings, Inc. (“Atlas” or “We” or the “Company”) commenced operations on December 31, 2010. The primary business of Atlas is underwriting commercial automobile insurance in the United States (“U.S.”), with a niche market orientation and focus on insurance for the “light” commercial automobile sector. This sector includes taxi cabs, non-emergency para-transit, limousine, livery, including certain transportation network companies (“TNC”) drivers/operators, and business autos. Automobile insurance products provide insurance coverage in three major areas: liability, accident benefits and physical damage. Liability insurance provides coverage, subject to policy terms and conditions where the insured is determined to be responsible and/or liable for an automobile accident, for the payment for injuries and property damage to third parties. Accident benefit policies or personal injury protection policies provide coverage for loss of income, medical and rehabilitation expenses for insured persons who are injured in an automobile accident, regardless of fault. Physical damage coverage subject to policy terms and conditions provides for the payment of damages to an insured automobile arising from a collision with another object or from other risks such as fire or theft. In the short run, automobile physical damage and liability coverage generally provides more predictable results than automobile accident benefit or personal injury insurance. Atlas’ business is carried out through its “Insurance Subsidiaries”: American Country Insurance Company (“American Country”), American Service Insurance Company, Inc. (“American Service”), Gateway Insurance Company (“Gateway”), and Global Liberty Insurance Company of New York (“Global Liberty”); and other non-insurance company subsidiaries: Anchor Group Management Inc. (“AGMI”), Plainview Premium Finance Company, Inc. (“Plainview Delaware”), UBI Holdings Inc. (“UBI Holdings”) and UBI Holdings’ wholly-owned subsidiaries, optOn Digital IP Inc. (“OOIP”) and optOn Insurance Agency Inc. (“optOn” and together with OOIP and UBI Holdings, “UBI”). The Insurance Subsidiaries distribute their insurance products through AGMI, which has contracted a network of retail independent agents. Together, the Insurance Subsidiaries are licensed to write property and casualty (“P&C”) insurance in 49 states and the District of Columbia in the U.S. Atlas’ core products are actively distributed in 42 of those states plus the District of Columbia. The Insurance Subsidiaries and the Company’s other non-insurance subsidiaries share common management and operating infrastructure. During the third quarter of 2019, new business writings were restricted or stopped in connection with certain of the Insurance Subsidiaries. See “Explanatory Note” and “Part I, Item 2, 2019 Developments” for certain developments with respect to the Company and the Insurance Subsidiaries during the third quarter and subsequent to September 30, 2019. Atlas’ ordinary voting common shares are listed on the NASDAQ under the symbol “AFH”. Basis of Presentation These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of Atlas and the entities it controls. All significant intercompany accounts and transactions have been eliminated. The results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results expected for the full calendar year. The accompanying unaudited condensed consolidated financial statements, in accordance with Securities and Exchange Commission (“SEC”) rules for interim periods, do not include all of the information and notes required by U.S. GAAP for complete financial statements and should be read in conjunction with Atlas’ Annual Report on Form 10-K for the year ended December 31, 2018 , which provides a more complete understanding of the Company’s accounting policies, financial position, operating results, business properties, and other matters. Atlas has consistently applied the same accounting policies throughout all periods presented. Estimates and Assumptions The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates and changes in estimates are recorded in the accounting period in which they are determined. The liability for unpaid claims and claims adjustment expenses and related amounts recoverable from reinsurers represent the most significant estimates in the accompanying condensed consolidated financial statements, and differences between such estimates and actual results could be material. Significant estimates in the accompanying financial statements also include the fair values of investments, deferred policy acquisition cost recoverability, and deferred tax asset valuation. Seasonality The P&C insurance business is seasonal in nature. While Atlas’ net premiums earned are generally stable from quarter to quarter, Atlas’ gross premiums written follow the common renewal dates for the “light” commercial risks that represent its core lines of business. For example, January 1 and March 1 are common taxi cab renewal dates in Illinois and New York, respectively. Our New York “excess taxi program” has an annual renewal date in the third quarter. Net underwriting results are driven mainly by the timing and nature of claims, which can vary widely. Operating Segments The Company operates in one business segment, the P&C insurance business.

New Accounting Standards

New Accounting Standards	9 Months Ended
	Sep. 30, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New Accounting Standards	New Accounting Standards With the exception of the accounting and disclosure pronouncements discussed below, there have been no recent pronouncements or changes in pronouncements during the nine months ended September 30, 2019 , as compared to those described in our Annual Report on Form 10-K for the twelve months ended December 31, 2018 , that are of significance or potential significance to Atlas. Pertinent Accounting Standard Updates (“ASUs”) are issued from time to time by the Financial Accounting Standards Board (“FASB”) and are adopted by the Company as they become effective. All recently issued accounting pronouncements with effective dates prior to October 1, 2019 have been adopted by the Company. Recently Adopted Leases In March 2019, December 2018, July 2018 and February 2016, the FASB issued ASU 2019-01 Leases (Topic 842) Codification Improvements, ASU 2018-20 Leases (Topis 842) Narrow-Scope Improvements for Lessors, ASU 2018-11 Leases (Topic 842): Targeted Improvements and ASU 2018-10 Codification Improvements to Topic 842, Leases and ASU 2016-02, Leases (Topic 842), respectively. The provisions of these updates impact the classification criteria, disclosure requirements, and other specific transactions in lease accounting. The updates require either the use of a modified retrospective approach, which requires leases to be measured at the beginning of the earliest period presented, or the transition method, which requires entities to recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The Company adopted the updates on January 1, 2019 using the transition method with no change to comparative periods. See ‘Part I, Item 1, Note 16, Leases, for further discussion of the future lease commitments. The adoption of these updates resulted in the recognition of both a right-of-use asset and lease liability in the amounts of approximately $2.6 million and $3.2 million , respectively. There was no impact to any of Atlas’ current financial covenants as a result of the increase to reported liabilities. Premium Amortization on Purchased Callable Debt Securities In March 2017, the FASB issued ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities. This guidance shortens the amortization period to the earliest call date for certain purchased callable debt securities held at a premium that have explicit, noncontingent call features and are callable at a fixed price and preset date. For public entities, this guidance is effective for years beginning after December 15, 2018, including interim periods within those years. The Company adopted the update on January 1, 2019 with no impact on the Company’s consolidated financial statements because Atlas’ callable debt securities, that are held at a premium, are amortized to the earliest call date, which is consistent with current accounting treatment.

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2019
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible Assets	Intangible Assets Intangible Assets by Major Asset Class ($ in ‘000s) Economic Useful Life Gross Carrying Amount Accumulated Amortization Net As of September 30, 2019 Trade name and trademark 15 years $ 1,800 $ 551 $ 1,249 Customer relationship 10 years 2,700 1,227 1,473 State insurance licenses Indefinite 740 — 740 $ 5,240 $ 1,778 $ 3,462 As of December 31, 2018 Trade name and trademark 15 years $ 1,800 $ 459 $ 1,341 Customer relationship 10 years 2,700 1,026 1,674 State insurance licenses Indefinite 740 — 740 $ 5,240 $ 1,485 $ 3,755

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per Share Computations of Basic and Diluted Earnings per Common Share ($ in ‘000s, except share and per share amounts) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Basic (Loss) income from operations before income taxes $ (2,216 ) $ 7,123 $ (6,168 ) $ 21,014 Income tax expense 26 1,518 26 4,304 Net (loss) income attributable to common shareholders $ (2,242 ) $ 5,605 $ (6,194 ) $ 16,710 Basic weighted average common shares outstanding 11,954,494 11,936,970 11,954,494 12,014,817 Earnings per common share basic $ (0.19 ) $ 0.47 $ (0.52 ) $ 1.39 Diluted Basic weighted average common shares outstanding 11,954,494 11,936,970 11,954,494 12,014,817 Dilutive potential ordinary shares: Dilutive stock options outstanding — 14,247 — 16,921 Diluted weighted average common shares outstanding 11,954,494 11,951,217 11,954,494 12,031,738 Earnings per common share diluted $ (0.19 ) $ 0.47 $ (0.52 ) $ 1.39 Common shares are defined as ordinary voting common shares, restricted voting common shares and participative restricted stock units (“RSUs”). Earnings per common share diluted is computed by dividing net income by the weighted average number of common shares outstanding for each period plus the incremental number of shares added as a result of converting dilutive potential ordinary voting common shares, calculated using the treasury stock method (or, in the case of the convertible preferred shares, using the “if-converted” method). Atlas’ dilutive potential ordinary voting common shares consist of outstanding stock options to purchase ordinary voting common shares. The effects of these convertible instruments are excluded from the computation of earnings per common share diluted in periods in which the effect would be anti-dilutive. For the three and nine months ended September 30, 2019 , all exercisable stock options were deemed to be anti-dilutive. For the three and nine months ended September 30, 2018 , all exercisable stock options were deemed to be dilutive.

Investments

Investments	9 Months Ended
	Sep. 30, 2019
Investments [Abstract]
Investments	Investments Cost or Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments ($ in ‘000s) Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value September 30, 2019 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 22,438 $ 203 $ (41 ) $ 22,600 States, municipalities and political subdivisions 3,904 98 (3 ) 3,999 Corporate Banking/financial services 5,059 124 — 5,183 Consumer goods 2,397 34 (1 ) 2,430 Capital goods 1,152 57 — 1,209 Energy 1,987 76 — 2,063 Telecommunications/utilities 4,215 91 (4 ) 4,302 Health care 499 3 (70 ) 432 Total corporate 15,309 385 (75 ) 15,619 Mortgage-backed Agency 11,136 116 (49 ) 11,203 Commercial 12,642 279 (42 ) 12,879 Total mortgage-backed 23,778 395 (91 ) 24,082 Other asset-backed 11,995 69 (1 ) 12,063 Total fixed income securities $ 77,424 $ 1,150 $ (211 ) $ 78,363 December 31, 2018 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 20,522 $ 30 $ (356 ) $ 20,196 States, municipalities and political subdivisions 8,970 19 (146 ) 8,843 Corporate Banking/financial services 13,482 9 (367 ) 13,124 Consumer goods 10,108 1 (319 ) 9,790 Capital goods 3,711 36 (200 ) 3,547 Energy 7,191 — (379 ) 6,812 Telecommunications/utilities 8,647 1 (325 ) 8,323 Health care 832 — (77 ) 755 Total corporate 43,971 47 (1,667 ) 42,351 Mortgage-backed Agency 25,778 6 (656 ) 25,128 Commercial 20,091 105 (574 ) 19,622 Total mortgage-backed 45,869 111 (1,230 ) 44,750 Other asset-backed 13,881 13 (43 ) 13,851 Total fixed income securities $ 133,213 $ 220 $ (3,442 ) $ 129,991 Amortized Cost and Fair Value of Fixed Income Securities by Contractual Maturity ($ in ‘000s) Amortized Cost Fair Value As of September 30, 2019 One year or less $ 5,396 $ 5,390 One to five years 25,814 26,038 Five to ten years 9,509 9,816 More than ten years 932 974 Total contractual maturity 41,651 42,218 Total mortgage and asset backed 35,773 36,145 Total $ 77,424 $ 78,363 As certain securities and debentures have the right to call or prepay obligations, the actual settlement dates may differ from contractual maturity. Atlas assesses, on a quarterly basis, whether there is evidence that a financial asset or group of financial assets is impaired. An investment is considered impaired when the fair value of the investment is less than its cost or amortized cost. When an investment is impaired, the Company must make a determination as to whether the impairment is other-than-temporary. Management performs a quarterly analysis of Atlas’ investment holdings to determine if declines in fair value are other-than-temporary. The analysis includes some or all of the following procedures as deemed appropriate by management: • identifying all security holdings in unrealized loss positions that have existed for at least six months or other circumstances that management believes may impact the recoverability of the security; • obtaining a valuation analysis from third party investment managers regarding these holdings based on their knowledge, experience and other market-based valuation techniques; • reviewing the trading range of certain securities over the preceding calendar period; • assessing whether declines in market value are other-than-temporary for debt security holdings based on credit ratings from third party security rating agencies; and • determining the necessary provision for declines in market value that are considered other-than-temporary based on the analyses performed. The risks and uncertainties inherent in the assessment methodology utilized to determine declines in market value that are other-than-temporary include, but may not be limited to, the following: • the opinion of professional investment managers could prove to be incorrect; • the past trading patterns of individual securities may not reflect future valuation trends; • the credit ratings assigned by independent credit rating agencies may prove to be incorrect due to unforeseen or unknown facts related to a company’s financial situation; and • the debt service pattern of non-investment grade securities may not reflect future debt service capabilities and may not reflect a company’s unknown underlying financial problems. Under U.S. GAAP, with respect to an investment in an impaired debt security, other-than-temporary impairment (“OTTI”) occurs if (a) there is intent to sell the debt security, (b) it is more likely than not it will be required to sell the debt security before its anticipated recovery, or (c) it is probable that all amounts due will be unable to be collected such that the entire cost basis of the security will not be recovered. If Atlas intends to sell the debt security, or will more likely than not be required to sell the debt security before the anticipated recovery, a loss in the entire amount of the impairment is reflected in net investment gains (losses) on investments in the condensed consolidated statements of (loss) income . If Atlas determines that it is probable it will be unable to collect all amounts and Atlas has no intent to sell the debt security, a credit loss is recognized in net investment gains (losses) on investments in the condensed consolidated statements of (loss) income to the extent that the present value of expected cash flows is less than the amortized cost basis; any difference between fair value and the new amortized cost basis (net of the credit loss) is reflected in other comprehensive income (loss) , net of applicable income taxes. For equity securities, the Company evaluates its ability to retain its investment in the issuer for a period of time sufficient to allow for any anticipated recovery in fair value. Evidence considered to determine anticipated recovery are analysts’ reports on the near-term prospects of the issuer and the financial condition of the issuer or the industry, in addition to the length and extent of the market value decline. If an OTTI is identified, the equity security is adjusted to fair value through a realized loss in earnings. There were no other-than-temporary impairments recorded for the three and nine months ended September 30, 2019 and 2018 as a result of the OTTI analysis performed by management. Aging of Unrealized Losses in Fixed Income Securities ($ in ‘000s) Less Than 12 Months More Than 12 Months Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses September 30, 2019 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 3,283 $ (18 ) $ 5,303 $ (23 ) $ 8,586 $ (41 ) States, municipalities and political subdivisions — — 507 (3 ) 507 (3 ) Corporate Banking/financial services 220 — — — 220 — Consumer goods 119 — 263 (1 ) 382 (1 ) Telecommunications/utilities 303 — 184 (4 ) 487 (4 ) Health care — — 299 (70 ) 299 (70 ) Total corporate 642 — 746 (75 ) 1,388 (75 ) Mortgage-backed Agency 1,165 (7 ) 3,538 (42 ) 4,703 (49 ) Commercial 1,152 (6 ) 2,754 (36 ) 3,906 (42 ) Total mortgage-backed 2,317 (13 ) 6,292 (78 ) 8,609 (91 ) Other asset-backed 223 — 204 (1 ) 427 (1 ) Total fixed income securities $ 6,465 $ (31 ) $ 13,052 $ (180 ) $ 19,517 $ (211 ) December 31, 2018 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 507 $ — $ 15,857 $ (356 ) $ 16,364 $ (356 ) States, municipalities and political subdivisions 1,687 (27 ) 4,875 (119 ) 6,562 (146 ) Corporate Banking/financial services 8,376 (235 ) 3,861 (132 ) 12,237 (367 ) Consumer goods 5,442 (176 ) 4,132 (143 ) 9,574 (319 ) Capital goods 1,727 (135 ) 1,430 (65 ) 3,157 (200 ) Energy 4,516 (295 ) 2,296 (84 ) 6,812 (379 ) Telecommunications/utilities 3,806 (99 ) 4,259 (226 ) 8,065 (325 ) Health care 127 (2 ) 628 (75 ) 755 (77 ) Total corporate 23,994 (942 ) 16,606 (725 ) 40,600 (1,667 ) Mortgage-backed Agency 5,035 (72 ) 19,210 (584 ) 24,245 (656 ) Commercial 5,256 (149 ) 11,062 (425 ) 16,318 (574 ) Total mortgage-backed 10,291 (221 ) 30,272 (1,009 ) 40,563 (1,230 ) Other asset-backed 9,568 (22 ) 1,748 (21 ) 11,316 (43 ) Total fixed income securities $ 46,047 $ (1,212 ) $ 69,358 $ (2,230 ) $ 115,405 $ (3,442 ) As of September 30, 2019 , we held 75 individual fixed income securities that were in an unrealized loss position, of which 50 individual fixed income securities were in a continuous loss position for longer than 12 months. As of December 31, 2018 , we held 391 individual fixed income and equity securities that were in an unrealized loss position, of which 246 individual fixed income securities were in a continuous loss position for longer than 12 months. We did not recognize the unrealized losses in earnings on these fixed income securities for the three and nine months ended September 30, 2019 or for the year ended December 31, 2018 . The Company expects to monitor liquidity needs and assess the sale of fixed income assets, if required, on a regular basis. Components of Net Investment Income ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Total investment income: Interest income $ 686 $ 1,006 $ 2,448 $ 3,139 Income from other investments 32 326 782 793 Investment expenses (290 ) (262 ) (950 ) (731 ) Net investment income $ 428 $ 1,070 $ 2,280 $ 3,201 Aggregate Proceeds and Gross Realized Investment Gains and Losses ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Fixed income securities: Proceeds from sales and calls $ 13,520 $ 7,905 $ 53,174 $ 44,262 Gross realized investment gains 169 27 548 280 Gross realized investment losses (54 ) (82 ) (352 ) (539 ) Equities: Proceeds from sales $ — $ 524 $ 5,997 $ 5,373 Gross realized investment gains — 94 443 730 Gross realized investment losses — — (96 ) (26 ) Other investments: Proceeds from sales $ 1,700 $ 15 $ 3,997 $ 56 Gross realized investment gains 298 15 576 56 Total: Proceeds from sales and calls $ 15,220 $ 8,444 $ 63,168 $ 49,691 Gross realized investment gains 467 136 1,567 1,066 Gross realized investment losses (54 ) (82 ) (448 ) (565 ) Components of Net Realized Gains (Losses) ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Fixed income securities $ 115 $ (55 ) $ 196 $ (259 ) Equities — 94 347 704 Other investments 296 15 548 56 Net realized gains $ 411 $ 54 $ 1,091 $ 501 Other Investments Atlas’ other investments are comprised of collateral loans and various limited partnerships that invest in income-producing real estate, equities, or insurance linked securities. Atlas accounts for these limited partnership investments using the equity method of accounting. The carrying values of the equity method limited partnerships were $19.4 million and $24.0 million as of September 30, 2019 and December 31, 2018 , respectively. The carrying value of these investments is Atlas’ share of the net book value for each limited partnership. The carrying values of the collateral loans were $93,000 and $1.0 million as of September 30, 2019 and December 31, 2018 , respectively. Equity Method Investments by Type ($ in ‘000s) Unfunded Commitments Carrying Value September 30, 2019 September 30, 2019 December 31, 2018 Real estate $ 2,887 $ 11,063 $ 11,085 Insurance linked securities — 1,378 6,694 Activist hedge funds — 3,920 3,911 Venture capital 2,390 2,682 2,015 Other joint venture — 325 325 Total equity method investments $ 5,277 $ 19,368 $ 24,030 Due to the timing of financial information of the Company’s equity method investments, certain investments are recorded on a financial reporting lag of one to three months. The Company recognizes an impairment loss for equity method limited partnerships when evidence demonstrates that the loss is other-than-temporary. To determine if an other-than-temporary impairment has occurred, the Company evaluates whether or not the investee could sustain a level of earnings that would justify the carrying amount of the investment. Collateral loans are considered impaired when it is probable that the Company will not collect the contractual principal and interest. Valuation allowances are established for impaired loans equal to the fair value of the collateral less costs to sell or the present value of the loan’s expected future repayment cash flows discounted at the loan’s original effective interest rate. Valuation allowances are adjusted for subsequent changes in the fair value of the collateral less costs to sell or the present value of the loan’s expected future repayment cash flows. As of September 30, 2019 and December 31, 2018 , the Company had no valuation allowances established for impaired equity method limited partnerships and loans. Short-Term Investments Atlas’ short-term investments are comprised of fixed income securities. As of September 30, 2019 and December 31, 2018 , short-term investments totaled $8.6 million and $4.7 million , respectively. Collateral Pledged As of September 30, 2019 and December 31, 2018 , bonds, cash and cash equivalents with a fair value of $16.9 million and $14.9 million , respectively, were on deposit with state and provincial regulatory authorities. Also, from time to time, the Company pledges securities to and deposits cash with third parties to collateralize liabilities incurred under its policies of reinsurance assumed and other commitments made by the Company. As of September 30, 2019 and December 31, 2018 , the amounts of such pledged securities were $49.4 million and $31.3 million , respectively. Collateral pledging transactions are conducted under terms that are common and customary to standard collateral pledging and are subject to the Company’s standard risk management controls. These assets and investment income related thereto remain the property of the Company while pledged. Neither the state and/or provincial regulatory authorities nor any other third party has the right to re-pledge or sell said securities held on deposit.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments U.S. GAAP requires certain assets and liabilities to be reported at fair value in the financial statements and provides a framework for establishing that fair value. Level 1 inputs are given the highest priority in the hierarchy, while Level 3 inputs are given the lowest priority. Assets and liabilities carried at fair value are classified in one of the following three categories based on the nature of the inputs to the valuation technique used: Level 1 Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities in active markets as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3 Unobservable inputs that are not corroborated by market data. These inputs reflect management’s best estimate of fair value using its own assumptions about the assumptions a market participant would use in pricing the asset or liability. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Atlas’ assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the placement of the asset or liability within the fair value hierarchy levels. The following is a summary of significant valuation techniques for assets measured at fair value on a recurring basis: Level 1 U.S. treasury and other U.S. government obligations Comprised of certain U.S. Treasury fixed income securities. Valuation is based on unadjusted quoted prices for identical assets in active markets that Atlas can access. Equities Comprised of publicly-traded common stocks. Valuation is based on unadjusted quoted prices for identical assets in active markets that Atlas can access. Level 2 States, municipalities and political subdivisions Comprised of U.S. States, Territories and Possessions, U.S. Political Subdivisions of States, Territories and Possessions, U.S. Special Revenue and Special Assessment Obligations. The primary inputs to the valuation include quoted prices for identical assets in inactive markets or similar assets in active or inactive markets, contractual cash flows, benchmark yields and credit spreads. Corporate bonds Comprised of investment-grade fixed income securities. The primary inputs to the valuation include quoted prices for identical assets in inactive markets or similar assets in active or inactive markets, contractual cash flows, benchmark yields and credit spreads. Mortgage-backed and other asset-backed Comprised of securities that are collateralized by mortgage obligations and other assets. The primary inputs to the valuation include quoted prices for identical assets in inactive markets or similar assets in active or inactive markets, contractual cash flows, benchmark yields, collateral performance and credit spreads. Investments at Fair Value ($ in ‘000s) Level 1 Level 2 Level 3 Total As of September 30, 2019 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 22,600 $ — $ — $ 22,600 States, municipalities and political subdivisions — 3,999 — 3,999 Corporate Banking/financial services — 5,183 — 5,183 Consumer goods — 2,430 — 2,430 Capital goods — 1,209 — 1,209 Energy — 2,063 — 2,063 Telecommunications/utilities — 4,302 — 4,302 Health care — 432 — 432 Total corporate — 15,619 — 15,619 Mortgage-backed Agency — 11,203 — 11,203 Commercial — 12,879 — 12,879 Total mortgage-backed — 24,082 — 24,082 Other asset-backed — 12,063 — 12,063 Total fixed income securities $ 22,600 $ 55,763 $ — $ 78,363 Equities 1 — — 1 Total $ 22,601 $ 55,763 $ — $ 78,364 As of December 31, 2018 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 20,196 $ — $ — $ 20,196 States, municipalities and political subdivisions — 8,843 — 8,843 Corporate Banking/financial services — 13,124 — 13,124 Consumer goods — 9,790 — 9,790 Capital goods — 3,547 — 3,547 Energy — 6,812 — 6,812 Telecommunications/utilities — 8,323 — 8,323 Health care — 755 — 755 Total corporate — 42,351 — 42,351 Mortgage-backed Agency — 25,128 — 25,128 Commercial — 19,622 — 19,622 Total mortgage-backed — 44,750 — 44,750 Other asset-backed — 13,851 — 13,851 Total fixed income securities $ 20,196 $ 109,795 $ — $ 129,991 Equities 5,929 — — 5,929 Total $ 26,125 $ 109,795 $ — $ 135,920 Atlas primarily uses the services of external securities pricing vendors to obtain these values. Atlas then reviews these valuations to ensure that the values are accurately recorded and that the data inputs and valuation techniques utilized are appropriate, consistently applied, and that the assumptions are reasonable and consistent with the objective of determining fair value. Though Atlas believes the valuation methods used in determining fair value are appropriate, different methodologies or assumptions could result in a different fair value as of September 30, 2019 . Management does not believe that reasonable changes to the inputs to its valuation methodology would result in a significantly higher or lower fair value measurement. The Company had no fair value investments classified as Level 3 as of September 30, 2019 or December 31, 2018 . There were no transfers in or out of Level 2 or Level 3 during the three and nine months ended September 30, 2019 and 2018 .

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Atlas’ effective tax rate was (1.2)% and 21.3% for the three months ended September 30, 2019 and 2018 , respectively, and (0.4)% and 20.5% for the nine months ended September 30, 2019 and 2018 , respectively. Reconciliation of U.S. Statutory Marginal Income Tax Rate to the Effective Tax Rate ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Amount % Amount % Amount % Amount % Provision for taxes at U.S. statutory marginal income tax rate $ (465 ) 21.0 % $ 1,496 21.0 % $ (1,295 ) 21.0 % $ 4,413 21.0 % Provision for deferred tax assets deemed unrealizable (valuation allowance) 469 (21.2 ) — — 1,246 (20.2 ) — — Nondeductible expenses 2 (0.1 ) 25 0.3 27 (0.5 ) 53 0.2 Tax-exempt income (1 ) — (3 ) — (4 ) 0.1 (9 ) — State tax (net of federal benefit) 21 (0.9 ) — — 21 (0.3 ) (2 ) — Stock compensation — — — — 31 (0.5 ) (42 ) (0.2 ) Nondeductible acquisition accounting adjustment — — — — — — (109 ) (0.5 ) Provision for income taxes for continuing operations $ 26 (1.2 )% $ 1,518 21.3 % $ 26 (0.4 )% $ 4,304 20.5 % Components of Income Tax Expense (Benefit) ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Current tax expense (benefit) $ 26 $ (145 ) $ 26 $ (441 ) Deferred tax (benefit) expense (469 ) 1,663 (1,246 ) 4,745 Change in deferred tax valuation allowance 469 — 1,246 — Total $ 26 $ 1,518 $ 26 $ 4,304 Upon the transaction forming Atlas on December 31, 2010, a yearly limitation as required by U.S. Internal Revenue Code of 1986 (as amended, “IRC”) Section 382 that applies to changes in ownership on the future utilization of Atlas’ net operating loss carryforwards was calculated. The Insurance Subsidiaries’ prior parent retained those tax assets previously attributed to the Insurance Subsidiaries, which could not be utilized by Atlas as a result of this limitation. As a result, Atlas’ ability to recognize future tax benefits associated with a portion of its deferred tax assets generated during prior years has been permanently limited to the amount determined under IRC Section 382. The result is a maximum expected net deferred tax asset that Atlas has available after the merger, which is believed more likely than not to be utilized in the future, after consideration of the valuation allowance. On July 22, 2013, due to shareholder activity, a “triggering event” as determined under IRC Section 382 occurred. As a result, under IRC Section 382, the use of the Company’s net operating loss and other carryforwards generated prior to the “triggering event” will be limited as a result of this “ownership change” for tax purposes, which is defined as a cumulative change of more than 50% during any three-year period by shareholders owning 5% or greater portions of the Company’s shares. Due to this triggering event, the Company estimates that it will retain total tax effected federal net operating loss carryforwards (“NOLs”) of approximately $27.3 million as of September 30, 2019 . Components of Deferred Income Tax Assets and Liabilities ($ in ‘000s) September 30, 2019 December 31, 2018 Gross deferred tax assets: Losses carried forward $ 27,321 $ 25,326 Claims liabilities and unearned premium reserves 4,352 5,949 Bad debts 1,195 1,009 Stock compensation 834 760 Other 228 418 Valuation allowance (29,788 ) (29,416 ) Total gross deferred tax assets 4,142 4,046 Gross deferred tax liabilities: Deferred policy acquisition costs 1,011 1,535 Investments 1,088 189 Fixed assets 1,258 1,371 Intangible assets 572 633 Other 213 318 Total gross deferred tax liabilities 4,142 4,046 Net deferred tax assets $ — $ — Net Operating Loss Carryforward as of September 30, 2019 by Expiry ($ in ‘000s) Year of Occurrence Year of Expiration Amount 2001 2021 $ 5,007 2002 2022 4,317 2006 2026 7,825 2007 2027 5,131 2008 2028 1,949 2009 2029 1,949 2010 2030 1,949 2011 2031 4,166 2012 2032 9,236 2015 2035 1 2017 2037 27,313 2018 2038 47,653 2018 Indefinite 4,106 2019 2039 4,957 2019 Indefinite 4,543 Total $ 130,102 NOLs and other carryforwards generated in 2018 and 2019 are not limited by IRC Section 382. Deferred tax assets are recognized to the extent that it is probable that future taxable income will be available against which they can be utilized. When considering the extent of the valuation allowance on Atlas’ deferred tax assets, weight is given by management to both positive and negative evidence. U.S. GAAP states that a cumulative loss in recent years is a significant piece of negative evidence that is difficult to overcome in determining that a valuation allowance is not needed against deferred tax assets. Based on Atlas’ cumulative loss in recent years, Atlas has recorded a valuation allowance of $29.8 million and $29.4 million for its gross future deferred tax assets as of September 30, 2019 and December 31, 2018 , respectively. Atlas accounts for uncertain tax positions in accordance with the income taxes accounting guidance. Atlas has analyzed filing positions in the federal and state jurisdictions where it is required to file tax returns, as well as the open tax years in these jurisdictions. Atlas believes that its federal and state income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain federal and state income tax positions have been recorded. Atlas would recognize interest and penalties related to unrecognized tax benefits as a component of the provision for federal income taxes. Atlas did not incur any federal income tax related interest income, interest expense or penalties for the three and nine months ended September 30, 2019 and 2018 . Tax year 2015 and years thereafter are subject to examination by the Internal Revenue Service (“IRS”).

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company has entered into subscription agreements to allow for participation by the Company in limited liability investments, which invest in income-producing real estate, equities and insurance linked securities. As of September 30, 2019 , the unfunded commitments are $5.3 million . In the ordinary course of its business, Atlas is involved in legal proceedings, including lawsuits, regulatory examinations and inquiries. See “Explanatory Note” and “Part I, Item 2, 2019 Developments” for certain developments with respect to the Company and the Insurance Subsidiaries during the third quarter and subsequent to September 30, 2019 and see also “Part II, Item 1, Legal Proceedings”. Atlas is exposed to credit risk on balances receivable from policyholders, agents and reinsurers. Credit exposure to any one individual policyholder is not material. The Company’s policies, however, are distributed by agents who may manage cash collection on its behalf pursuant to the terms of their agency agreement. Atlas has procedures to monitor and minimize its exposure to delinquent agent balances, including, but not limited to, reviewing account current statements, processing policy cancellations for non-payment and other collection efforts deemed appropriate. Atlas also has procedures to evaluate the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities, or economic characteristics of the reinsurers to minimize its exposure to significant losses from reinsurers’ insolvency. Virtually all states require insurers licensed to do business therein to bear a portion of contingent and incurred claims handling expenses and the unfunded amount of “covered” claims and unearned premium obligations of impaired or insolvent insurance companies, either up to the policy’s limit, the applicable guaranty fund covered claims obligation cap, or 100% of statutorily defined workers’ compensation benefits, subject to applicable deductibles. These obligations are funded by assessments, made on a retrospective, prospective or pre-funded basis, which are levied by guaranty associations within the state, up to prescribed limits (typically 2% of “net direct premiums written”), on all member insurers in the state on the basis of the proportionate share of the premiums written by member insurers in certain covered lines of business in which the impaired, insolvent or failed insurer was engaged. In addition, as a condition to the ability to conduct business in certain states (and within the jurisdiction of some local governments), insurance companies are subject to or required to participate in various premium or claims based insurance-related assessments, including non-voluntary assigned risk pools, underwriting associations, workers’ compensation second-injury funds, reinsurance funds and other state insurance facilities. Atlas’ proportionate share of these various premium or claims based insurance-related assessments, including non-voluntary assigned risk pools, underwriting associations, workers’ compensation second-injury funds, reinsurance funds and other state insurance facilities is not expected to be material.

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and Equipment Held 1 ($ in ‘000s) September 30, 2019 December 31, 2018 Buildings $ 7,425 $ 7,425 Land 1,840 1,840 Building improvements 9,023 9,006 Leasehold improvements 193 190 Internal use software 20,207 17,575 Computer equipment 1,923 1,821 Furniture and other office equipment 2,897 2,897 Total $ 43,508 $ 40,754 Accumulated depreciation (12,778 ) (9,391 ) Total property and equipment, net $ 30,730 $ 31,363 1 Excluding assets held for sale. Depreciation expense and amortization was $1.2 million and $696,000 for the three months ended September 30, 2019 and 2018 , respectively, and $3.4 million and $2.1 million for the nine months ended September 30, 2019 and 2018 , respectively. For the year ended December 31, 2018 , depreciation expense and amortization was $2.9 million . For the nine months ended September 30, 2019 , the Company capitalized $2.7 million of costs incurred, consisting primarily of external consultants and internal labor costs incurred during the application development stage for internal-use software. Substantially all of the costs incurred during the period were part of the application development stage. Amortization expense recorded for projects in the post-implementation/operation stage was $645,000 and $140,000 for the three months ended September 30, 2019 and 2018 , respectively, and $1.7 million and $420,000 for the nine months ended September 30, 2019 and 2018 , respectively . During 2016, Atlas purchased a building and land to serve as its new corporate headquarters to replace its former leased office space. Atlas’ Chicago area staff moved into this space in late October 2017 and occupies approximately 70,000 square feet in the building. An unrelated tenant occupies the remaining office space in the building. Rental income related to this lease agreement was $111,000 and $144,000 for the three months ended September 30, 2019 and 2018 , respectively, and $334,000 and $323,000 for the nine months ended September 30, 2019 and 2018 , respectively. Depreciation expense related to the building and its improvements was $283,000 and $277,000 for the three months ended September 30, 2019 and 2018 , respectively, and $850,000 and $819,000 for the nine months ended September 30, 2019 and 2018 , respectively. Loss on disposals of fixed assets was $2,000 and $28,000 for the three and nine months ended September 30, 2019 , respectively. There were no losses on disposals of fixed assets for the three and nine months ended September 30, 2018 .

Reinsurance Ceded

Reinsurance Ceded	9 Months Ended
	Sep. 30, 2019
Underwriting Policy and Reinsurance Ceded [Abstract]
Reinsurance Ceded	Reinsurance Ceded As is customary in the insurance industry, Atlas reinsures portions of certain insurance policies it writes, thereby providing a greater diversification of risk and minimizing exposure on larger risks. Atlas remains contingently at risk with respect to any reinsurance ceded and would incur an additional loss if an assuming company were unable to meet its obligation under the reinsurance treaty. Atlas monitors the financial condition of its reinsurers to minimize its exposure to significant losses from reinsurer insolvencies. Letters of credit are maintained for any unauthorized reinsurer to cover ceded unearned premium reserves, ceded claims and claims adjustment expense reserve balances and ceded paid claims. These policies mitigate the risk of credit quality or dispute from becoming a danger to financial strength. To date, the Company has not experienced any material difficulties in collecting reinsurance recoverables. Premiums Written, Premiums Earned and Amounts Related to Reinsurance ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Direct premiums written $ 30,728 $ 67,849 $ 160,529 $ 204,697 Assumed premiums written 4,478 8,068 27,319 24,168 Ceded premiums written (13,521 ) (27,756 ) (83,796 ) (63,753 ) Net premiums written $ 21,685 $ 48,161 $ 104,052 $ 165,112 Direct premiums earned $ 57,357 $ 65,519 $ 182,581 $ 192,497 Assumed premiums earned 9,692 6,113 27,371 15,048 Ceded premiums earned (26,467 ) (17,171 ) (78,080 ) (41,833 ) Net premiums earned $ 40,582 $ 54,461 $ 131,872 $ 165,712 Ceded claims and claims adjustment expenses $ 16,140 $ 16,420 $ 45,229 $ 28,449 Ceding commissions 5,308 3,427 19,557 11,421 During 2019, the Company received notice from General Reinsurance Corporation (“Gen Re”) that effective July 31, 2019, the XOL reinsurance coverage for American Country, American Service and Gateway (collectively, the “ASI Pool Companies”) would terminate on a cut-off basis. Additionally, effective September 30, 2019, the ASI Pool Companies’ Quota Share contract with Swiss Reinsurance America Corporation (“Swiss Re”) was terminated on a run-off basis. During 2020, the Company received notice from Gen Re that effective January 1, 2020, the XOL reinsurance coverage for Global Liberty would terminate on a run-off basis. See “Explanatory Note” and “Part I, Item 2, 2019 Developments” for certain developments with respect to the Company and the Insurance Subsidiaries during the third quarter and subsequent to September 30, 2019 .

Claims Liabilities

Claims Liabilities	9 Months Ended
	Sep. 30, 2019
Insurance Loss Reserves [Abstract]
Claims Liabilities	Claims Liabilities Changes in the Provision for Unpaid Claims and Claims Adjustment Expenses, Net of Reinsurance Recoverables ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Unpaid claims and claims adjustment expenses, beginning of period $ 252,670 $ 187,170 $ 273,496 $ 211,648 Less: reinsurance recoverable 72,229 46,614 68,771 53,402 Net unpaid claims and claims adjustment expenses, beginning of period 180,441 140,556 204,725 158,246 Incurred related to: Current year 27,601 33,621 93,935 101,109 Prior years 1,240 (79 ) 2,532 1,288 28,841 33,542 96,467 102,397 Paid related to: Current year 12,739 15,639 29,002 36,439 Prior years 31,682 26,563 107,329 92,308 44,421 42,202 136,331 128,747 Net unpaid claims and claims adjustment expenses, end of period 164,861 131,896 164,861 131,896 Add: reinsurance recoverable 79,105 55,085 79,105 55,085 Unpaid claims and claims adjustment expenses, end of period $ 243,966 $ 186,981 $ 243,966 $ 186,981 The process of establishing the estimated provision for unpaid claims and claims adjustment expenses is complex and imprecise, as it relies on the judgment and opinions of a large number of individuals, on historical precedent and trends, on prevailing legal, economic, social and regulatory trends, and on expectations as to future developments. The process of determining the provision necessarily involves risks that the actual results may deviate, perhaps substantially, from the best estimates made. The incurred related to prior years for the three and nine months ended September 30, 2019 and 2018 primarily resulted from unfavorable development on involuntary assigned risk pools and run-off commercial auto. Assigned risk pools are established by state governments to cover high-risk insureds who cannot purchase insurance through conventional means. See “Explanatory Note” and “Part I, Item 2, 2019 Developments” for certain developments with respect to the Company and the Insurance Subsidiaries during the third quarter and subsequent to September 30, 2019 .

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Sep. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Compensation	Share-Based Compensation On January 6, 2011, Atlas adopted a stock option plan (“Stock Option Plan”) in order to advance the interests of Atlas by providing incentives to eligible persons defined in the plan. In the second quarter of 2013, a new equity incentive plan (“Equity Incentive Plan”) was approved by the Company’s common shareholders at the Annual General Meeting, and Atlas ceased to grant new stock options under the preceding Stock Option Plan. The Equity Incentive Plan is a securities based compensation plan, pursuant to which Atlas may issue restricted stock grants for ordinary voting common shares, restricted stock, stock grants for ordinary voting common shares, stock options and other forms of equity incentives to eligible persons as part of their compensation. The Equity Incentive Plan is considered an amendment and restatement of the Stock Option Plan, although outstanding stock options issued pursuant to the Stock Option Plan will continue to be governed by the terms of the Stock Option Plan. Stock Options Stock Option Activity (prices in Canadian dollars designated with “C$” and U.S. dollars designated with “US$” Nine months ended September 30, 2019 2018 Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price C$ Denominated: Outstanding, beginning of period 27,195 C$6.00 54,390 C$6.00 Granted — — — — Exercised — — (27,195 ) C$6.00 Outstanding, end of period 27,195 C$6.00 27,195 C$6.00 US$ Denominated: Outstanding, beginning of period 375,000 US$17.01 375,000 US$17.01 Granted — — — — Exercised — — — — Outstanding, end of period 375,000 US$17.01 375,000 US$17.01 There are no stock options that are exercisable as of September 30, 2019 . The stock option grants outstanding have a weighted average remaining life of 4.73 years and have an intrinsic value of $0 as of September 30, 2019 . Under the Equity Incentive Plan, a director who either directly or indirectly purchases up to $100,000 of Atlas ordinary voting common stock on the open market, through the employee stock purchase plan, or via other means acceptable under this plan (see Note 13, ‘Other Employee Benefit Plans’) will receive a 3 to 1 matching grant of restricted stock grants for ordinary voting common shares (or for Canadian taxpayers, restricted stock units) based on the aggregate purchase price of ordinary voting common shares the director purchases during the 6 month period that began on June 18, 2013 and ended on December 31, 2013 , or for new directors within 6 months of their initial appointment date (the “Purchase Period”). Matching share grants of 148,152 restricted stock grants for ordinary voting common shares and 37,038 restricted stock units were made on February 28, 2014 (“Grant Date”). The number of ordinary voting common shares issued on the Grant Date were determined by dividing (A) the dollar amount of the Company matching contribution due based on purchases during the Purchase Period by (B) the closing common share price of one share of Company ordinary voting common stock at close of market on June 17, 2013 (“Closing Price”), which was $8.10 per share. The restricted stock grants for ordinary voting common shares will vest 20% on each anniversary of the Grant Date, subject to the terms of the grant agreement. The matching grant will be subject to all of the terms and conditions of the Equity Incentive Plan and applicable grant agreements. The matching grant award was discontinued during 2018 with no additional grants under the program since those discussed above. On December 31, 2018, the Company awarded restricted stock unit grants for ordinary voting common shares of the Company to its external directors pursuant to a director equity award agreement dated December 31, 2018. The awards, which were approved by the Company’s Board of Directors in March 2018, were valued at $40,000 per external director (“Aggregate Award”) and were made under the Company’s Equity Incentive Plan. The number of restricted stock units awarded was determined by dividing (A) the Aggregate Award by (B) the closing price of one share of Company ordinary voting common share at the close of market on April 4, 2018, which was $10.50 per share. For new directors, the Aggregate Award is proportionate to the director’s start date and priced as of that same day. During 2018, the Company awarded 17,524 RSU grants having an aggregate grant date fair value of $179,000 . The RSUs will vest 33.3% on January 1 of each year for the next three years. On March 12, 2015 , the Board of Directors of Atlas granted equity awards of (i) 200,000 restricted stock grants for ordinary voting common shares of the Company and (ii) 200,000 options to acquire ordinary voting common shares to the executive officers of the Company as part of the Company’s annual compensation process. The awards were made under the Company’s Equity Incentive Plan. The awards vest in five equal annual installments of 20% , provided that an installment shall not vest unless an annual performance target based on specific book value growth rates linked to return on equity goals is met. In the event the performance target is not met in any year, the 20% installment for such year shall not vest, but such non-vested installment shall carry forward and can become vested in future years (up to the fifth year from the date of grant), subject to achievement in a future year of the applicable performance target for such year. For the three and nine months ended September 30, 2019 and 2018 , no shares of either of the restricted stock grants for ordinary voting common shares or the options to acquire ordinary voting common shares vested due to not meeting annual performance targets. The Monte-Carlo simulation model was used, for both the options and restricted stock grants for ordinary voting common shares, to estimate the fair value of compensation expense as a result of the performance based component of these grants. Utilizing the Monte-Carlo simulation model, the fair values were $1.5 million and $1.9 million for the options and restricted stock grants for ordinary voting common shares, respectively. This expense will be amortized over the anticipated vesting period. Restricted Shares Restricted Stock Grants for Ordinary Voting Common Shares and Restricted Share Unit Activity Nine months ended September 30, 2019 2018 Number of Shares Weighted Average Fair Value at Grant Date Number of Shares Weighted Average Fair Value at Grant Date Non-vested, beginning of period 207,156 $ 16.50 234,080 $ 16.15 Granted — — — — Vested (28,066 ) 11.79 (44,448 ) 12.20 Canceled (7,408 ) 12.20 — — Non-vested, end of period 171,682 $ 17.46 189,632 $ 17.08 On February 21, 2019, an independent director of the Company notified Company management that they wished to cancel shares related to a February 2014 grant. In accordance with ASC 718 (Stock-Based Compensation), Atlas has recognized share-based compensation expense on a straight-line basis over the requisite service period of the last separately vesting portion of the award. Share-based compensation expense is a component of other underwriting expenses on the statements of income and comprehensive income. Atlas recognized $188,000 and $285,000 in share-based compensation expense, including income tax expense, for the three months ended September 30, 2019 and 2018 , respectively, and $685,000 and $856,000 for the nine months ended September 30, 2019 and 2018 , respectively. As of September 30, 2019 , there was $235,000 of unrecognized total compensation expense related to restricted stock and restricted stock units for ordinary voting common shares. The expense will be amortized over a weighted average period of 8 months.

Other Employee Benefit Plans

Other Employee Benefit Plans	9 Months Ended
	Sep. 30, 2019
Other Employee Benefit Plans [Abstract]
Other Employee Benefit Plans	Other Employee Benefit Plans Defined Contribution Plan Atlas has a defined contribution 401(k) plan covering all qualified employees of Atlas and its subsidiaries. Contributions to this plan are limited based on IRS guidelines. Atlas matches 100% of the employee contribution up to 2.5% of annual earnings, plus 50% of additional contributions up to 2.5% of annual earnings, for a total maximum expense of 3.75% of annual earnings per participant. Atlas’ matching contributions are discretionary. Employees are 100% vested in their own contributions and vest in Atlas contributions based on years of service equally over 5 years with 100% vested after 5 years. Company contributions were $159,000 and $139,000 for the three months ended September 30, 2019 and 2018 , respectively, and $493,000 and $419,000 for the nine months ended September 30, 2019 and 2018 , respectively. Employee Stock Purchase Plan The Atlas Employee Stock Purchase Plan (“ESPP”) encourages employee interest in the operation, growth and development of Atlas and provides an additional investment opportunity to employees. Full time and permanent part time employees working more than 30 hours per week are allowed to invest up to 7.5% of adjusted salary in Atlas ordinary voting common shares. Atlas matches 100% of the employee contribution up to 2.5% of annual earnings, plus 50% of additional contributions up to 5% of annual earnings, for a total maximum expense of 5% of annual earnings per participant. Atlas’ matching contributions are discretionary. Atlas also pays all administrative costs related to this plan. Atlas’ costs incurred related to the matching portion of the ESPP were $25,000 and $64,000 for the three months ended September 30, 2019 and 2018 , respectively, and $129,000 and $184,000 for the nine months ended September 30, 2019 and 2018 , respectively. Share purchases pursuant to this plan are made in the open market.

Share Capital and Mezzanine Equ

Share Capital and Mezzanine Equity	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Share Capital and Mezzanine Equity	Share Capital and Mezzanine Equity Share Capital Share Capital Activity September 30, 2019 December 31, 2018 Shares Authorized Shares Issued Shares Outstanding Amount ($ in ‘000s) Shares Issued Shares Outstanding Amount ($ in ‘000s) Ordinary voting common shares 266,666,667 12,198,319 11,942,812 $ 36 12,192,475 11,936,970 $ 36 Restricted voting common shares 33,333,334 — — — — — — Total common shares 300,000,001 12,198,319 11,942,812 $ 36 12,192,475 11,936,970 $ 36 There were 11,682 and 24,932 non-vested RSUs as of September 30, 2019 and December 31, 2018 , respectively. These RSUs are participative and are included in the computations of earnings per common share and book value per common share for these periods. During the nine months ended September 30, 2019 , the Company issued 5,842 ordinary voting common shares as a result of the vesting of RSUs. During the year ended December 31, 2018 , the Company issued 7,408 ordinary voting common shares as a result of the vesting of RSUs in addition to 27,195 ordinary voting common shares and immediately canceled 6,169 shares as a result of a cashless exercise of options. There were no options exercised during the nine months ended September 30, 2019 . On March 21, 2017, the Company’s Board of Directors approved a Share Repurchase Program of up to 650,000 shares of common stock. The repurchases could be made from time to time in open market transactions, privately-negotiated transactions, block purchases, or otherwise in accordance with securities laws at the discretion of the Company’s management until March 21, 2018. The Share Repurchase Program was not extended. The Company’s decisions around the timing, volume, and nature of share repurchases, and the ultimate amount of shares repurchased, was dependent on market conditions, applicable securities laws, and other factors. The Share Repurchase Program and the Board’s authorization of the program could have been modified, suspended, or discontinued at any time. During 2018, 255,505 shares were repurchased under the Share Repurchase Program. Mezzanine Equity There were no preferred shares outstanding as of September 30, 2019 and December 31, 2018 . Preferred shareholders are entitled to dividends on a cumulative basis, whether or not declared by the Board of Directors, at the rate of $0.045 per share per year ( 4.5% ) and may be paid in cash or in additional preferred shares at the option of Atlas. In liquidation, dissolution or winding-up of Atlas, preferred shareholders receive the greater of $1.00 per share plus all declared and unpaid dividends or the amount they would receive in liquidation if the preferred shares had been converted to restricted voting common shares or ordinary voting common shares immediately prior to liquidation. Preferred shareholders are not entitled to vote. During 2018, Atlas paid $333,000 in dividends earned on the preferred shares to the former owner of Anchor, the cumulative amount to which they were entitled through December 31, 2017, leaving no accrued or unpaid dividends.

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs	9 Months Ended
	Sep. 30, 2019
Deferred Policy Acquisition Costs Disclosures [Abstract]
Deferred Policy Acquisition Costs	Deferred Policy Acquisition Costs Components of Deferred Policy Acquisition Costs ($ in ‘000s) Nine months ended September 30, 2019 2018 Balance, beginning of period $ 7,309 $ 14,797 Acquisition costs deferred 7,466 13,954 Amortization charged to income (9,960 ) (18,357 ) Balance, end of period $ 4,815 $ 10,394

Leases

Leases	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Leases	Leases The Company adopted ASC 842 - Leases as of January 1, 2019, using the transition method wherein entities were allowed to initially apply the new lease standard at adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Accordingly, all periods prior to January 1, 2019 were presented in accordance with the previous ASC 840 - Leases, and no retrospective adjustments were made to the comparative periods presented. Adoption of ASC 842 resulted in an increase of operating lease right-of-use assets (“ROU”) totaling approximately $2.6 million in other assets on the condensed consolidated statements of financial positions and operating lease liabilities of approximately $3.2 million and a decrease of net deferred rent liabilities of approximately $600,000 in other liabilities and accrued expenses on the condensed consolidated statements of financial position as of January 1, 2019. We currently lease real estate space, automobiles, and certain equipment under non-cancelable operating lease agreements. Leases with an initial term of 12 months or less, which are immaterial to the Company, are not recorded in the condensed consolidated statement of financial position. The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized. The Company also elected the package of practical expedients permitted within the new standard, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases to lease payments based on changes in index rates or usage, are not recorded in the condensed consolidated statement of financial position. Certain agreements include an option to extend or renew the lease term at our option. The operating lease liability includes lease payments related to options to extend or renew the lease term if the Company is reasonably certain of exercising those options. Lease payments are discounted using the implicit discount rate in the lease. If the implicit discount rate for the lease cannot be readily determined, the Company uses an estimate of its incremental borrowing rate. AFH did not have any contracts accounted for as finance leases as of September 30, 2019 or January 1, 2019. Lease Expense ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2019 Operating leases $ 242 $ 720 Variable lease cost 90 256 Total $ 332 $ 976 Other Operating Lease Information ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2019 Cash paid for amounts included in the measurement of lease liabilities reported in operating cash flows $ 333 $ 977 Right-of-use assets obtained in exchange for new lease liabilities 54 54 Total $ 387 $ 1,031 Weighted-average remaining lease term 2.3 years Weighted-average discount rate 3.7 % The following table presents the undiscounted contractual maturities of the Company’s operating lease liability: Contractual Operating Lease Liabilities ($ in ‘000s) As of September 30, 2019 Remainder of 2019 $ 289 2020 1,103 2021 966 2022 181 2023 15 Total lease payments $ 2,554 Impact of discounting (80 ) Operating lease liability $ 2,474

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions During the periods presented, a portion of the Company’s investment portfolio, which is included in “Other investments” on the Condensed Consolidated Statements of Financial Position, included investment vehicles that are considered related-party transactions. As of September 30, 2019 and December 31, 2018 , these related-party transactions comprised 5.7% and 5.1% , respectively, of our investment portfolio. In these transactions, one or more of the Company’s directors or entities affiliated with such directors invest in and/or manage these vehicles. These related-party transactions are consistent with the Company’s investment guidelines and have been reviewed and approved by the Investment Committee of the Company’s Board of Directors. The Company believes that these transactions leverage investment resources that would otherwise not be available to the Company.

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Notes Payable	Notes Payable On April 26, 2017, Atlas issued $25 million of five -year 6.625% senior unsecured notes and received net proceeds of approximately $23.9 million after deducting underwriting discounts and commissions and other estimated offering expenses. Interest on the senior unsecured notes is payable quarterly on each January 26, April 26, July 26 and October 26. Atlas may, at its option, beginning with the interest payment date of April 26, 2020, and on any scheduled interest payment date thereafter, redeem the senior unsecured notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest to, but excluding, the date of redemption. The senior unsecured notes will rank senior in right of payment to any of Atlas’ existing and future indebtedness that is by its terms expressly subordinated or junior in right of payment to the senior unsecured notes. The senior unsecured notes will rank equally in right of payment to all of Atlas’ existing and future senior indebtedness, but will be effectively subordinated to any secured indebtedness to the extent of the value of the collateral securing such secured indebtedness. In addition, the senior unsecured notes will be structurally subordinated to the indebtedness and other obligations of Atlas’ subsidiaries. The senior unsecured notes were issued under an indenture and supplemental indenture that contain covenants that, among other things, limit: (i) the ability of Atlas to merge or consolidate, or lease, sell, assign or transfer all or substantially all of its assets; (ii) the ability of Atlas to sell or otherwise dispose of the equity securities of certain of its subsidiaries; (iii) the ability of certain of Atlas’ subsidiaries to issue equity securities; (iv) the ability of Atlas to permit certain of its subsidiaries to merge or consolidate, or lease, sell, assign or transfer all or substantially all of their respective assets; and (v) the ability of Atlas and its subsidiaries to incur debt secured by equity securities of certain of its subsidiaries. Interest expense on notes payable was $470,000 and $465,000 for the three months ended September 30, 2019 and 2018 , respectively, and $1.4 million and $1.4 million for each of the nine months ended September 30, 2019 and 2018 . Notes Payable Outstanding ($ in ‘000s) September 30, 2019 December 31, 2018 6.625% Senior Unsecured Notes due April 26, 2022 $ 25,000 $ 25,000 Unamortized issuance costs (577 ) (745 ) Total notes payable $ 24,423 $ 24,255

Statutory Information

Statutory Information	9 Months Ended
	Sep. 30, 2019
Statutory Information [Abstract]
Statutory Information	Statutory Information As a holding company, Atlas could derive cash from its Insurance Subsidiaries generally in the form of dividends to meet its obligations, which will primarily consist of operating expense payments and debt payments. Atlas’ Insurance Subsidiaries fund their obligations primarily through premium and investment income and maturities in the securities portfolio. The Insurance Subsidiaries require regulatory approval for the return of capital, loans or advances, and, in certain circumstances, prior to the payment of dividends. In the event that dividends available to the holding company are inadequate to cover its operating expenses and debt payments, the holding company would need to raise capital, sell assets or incur future debt. The Insurance Subsidiaries must each maintain a minimum statutory capital and surplus of $1.5 million , $2.4 million and $3.5 million under the provisions of the Illinois Insurance Code, the Missouri Insurance Code and the New York Insurance Code, respectively. Dividends may only be paid from statutory unassigned surplus, and payments may not be made if such surplus is less than a stipulated amount. The dividend restriction for the ASI Pool Companies is the greater of statutory net income or 10% of total statutory capital and surplus. The dividend restriction for Global Liberty is the lower of 10% of statutory surplus or 100% of adjusted net investment income for the preceding twelve months. See “Explanatory Note” and “Part I, Item 2, 2019 Developments” for certain developments with respect to the Company and the Insurance Subsidiaries during the third quarter and subsequent to September 30, 2019 . Statutory Net Loss and Surplus of Atlas’ Insurance Subsidiaries ($ in ‘000s) September 30, 2019 December 31, 2018 Net income (loss) computed under statutory-basis accounting $ 8,097 $ (49,648 ) Combined statutory capital and surplus $ 5,496 $ 14,377 Atlas did not declare or pay any dividends to its common shareholders during the nine months ended September 30, 2019 or during the year ended December 31, 2018 . During 2019, the Illinois Department of Insurance (the “Department”) placed all three of the ASI Pool Companies (after Gateway was redomesticated in Illinois) into rehabilitation with the Director of the Department as the statutory rehabilitator. While in rehabilitation, the operations of such insurance subsidiaries will be overseen by the statutory rehabilitator although Atlas continues to maintain its legal ownership of the stock of the ASI Pool Companies. Management’s overriding strategic plan continues to include a transition of business from these insurance companies to alternative markets within a reasonable period of time utilizing the existing platform of the MGA to work with strategic external insurance and reinsurance partners. Effective August 15, 2019, no new business was written by the ASI Pool Companies, and only New York area new business was written by Global Liberty, which is focusing its resources on New York area business to leverage the subsidiary’s heritage in this large and specific market. The ASI Pool Companies and Global Liberty continued to write renewal business that met their underwriting standards during 2019. Non-renewals related to ASI Pool Companies’ insurance policies began during the fourth quarter of 2019.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2019
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Throughout 2019, the Company has been exploring strategic alternatives, including, but not limited to, further strengthening its processes, reviewing its capital allocation and opportunities, a potential sale of the Company or certain assets, and balance sheet strengthening options with the goal of facilitating shareholder value generation. Atlas concluded that the utilization of its wholly owned managing general agency (“MGA”) operation to work with strategic external insurance and reinsurance partners will enable the Company to leverage its focus, experience and infrastructure to create value for stakeholders. The Company is working on additional arrangements with the objective of establishing MGA relationships in connection with the Company’s other lines of business as well. The Company agreed that should it choose to sell its MGA operations, 49% of the proceeds from any future sale of AGMI would be provided to the ASI Pool Companies to facilitate the rehabilitation process. There can be no assurance that any portion of the proceeds allocated to the ASI Pool Companies would be available for distribution to the Company. On January 22, 2020, the Company announced a non-binding letter of intent with Buckle, a technology-driven financial services company, to purchase the stock of Atlas’ indirect subsidiary Gateway and its corporate charter and forty-seven (47) state insurance licenses as well as state statutory deposits, subject to regulatory and other necessary approvals, for $4.7 million plus the value of all purchased deposits, such amount to be paid to the statutory rehabilitator for the benefit of the rehabilitation estate of Gateway, with a tentative closing date in April of 2020. The Company anticipates that Buckle will engage the MGA and certain other subsidiaries of the Company to provide services to Buckle and that Buckle will lease space at the Company’s headquarters and its Melville, NY office. The transaction will be subject to court approval and a bid process established by the statutory rehabilitator and approved by the court, and there can be no assurance that the transaction will be consummated on the terms described herein or at all.

Nature of Operations and Basi_2

Nature of Operations and Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of Atlas and the entities it controls. All significant intercompany accounts and transactions have been eliminated. The results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results expected for the full calendar year. The accompanying unaudited condensed consolidated financial statements, in accordance with Securities and Exchange Commission (“SEC”) rules for interim periods, do not include all of the information and notes required by U.S. GAAP for complete financial statements and should be read in conjunction with Atlas’ Annual Report on Form 10-K for the year ended December 31, 2018 , which provides a more complete understanding of the Company’s accounting policies, financial position, operating results, business properties, and other matters. Atlas has consistently applied the same accounting policies throughout all periods presented.
Estimates and Assumptions	Estimates and Assumptions The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates and changes in estimates are recorded in the accounting period in which they are determined. The liability for unpaid claims and claims adjustment expenses and related amounts recoverable from reinsurers represent the most significant estimates in the accompanying condensed consolidated financial statements, and differences between such estimates and actual results could be material. Significant estimates in the accompanying financial statements also include the fair values of investments, deferred policy acquisition cost recoverability, and deferred tax asset valuation.
Operating Segments	Operating Segments The Company operates in one business segment, the P&C insurance business.
New Accounting Standards	New Accounting Standards With the exception of the accounting and disclosure pronouncements discussed below, there have been no recent pronouncements or changes in pronouncements during the nine months ended September 30, 2019 , as compared to those described in our Annual Report on Form 10-K for the twelve months ended December 31, 2018 , that are of significance or potential significance to Atlas. Pertinent Accounting Standard Updates (“ASUs”) are issued from time to time by the Financial Accounting Standards Board (“FASB”) and are adopted by the Company as they become effective. All recently issued accounting pronouncements with effective dates prior to October 1, 2019 have been adopted by the Company. Recently Adopted Leases In March 2019, December 2018, July 2018 and February 2016, the FASB issued ASU 2019-01 Leases (Topic 842) Codification Improvements, ASU 2018-20 Leases (Topis 842) Narrow-Scope Improvements for Lessors, ASU 2018-11 Leases (Topic 842): Targeted Improvements and ASU 2018-10 Codification Improvements to Topic 842, Leases and ASU 2016-02, Leases (Topic 842), respectively. The provisions of these updates impact the classification criteria, disclosure requirements, and other specific transactions in lease accounting. The updates require either the use of a modified retrospective approach, which requires leases to be measured at the beginning of the earliest period presented, or the transition method, which requires entities to recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The Company adopted the updates on January 1, 2019 using the transition method with no change to comparative periods. See ‘Part I, Item 1, Note 16, Leases, for further discussion of the future lease commitments. The adoption of these updates resulted in the recognition of both a right-of-use asset and lease liability in the amounts of approximately $2.6 million and $3.2 million , respectively. There was no impact to any of Atlas’ current financial covenants as a result of the increase to reported liabilities. Premium Amortization on Purchased Callable Debt Securities In March 2017, the FASB issued ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities. This guidance shortens the amortization period to the earliest call date for certain purchased callable debt securities held at a premium that have explicit, noncontingent call features and are callable at a fixed price and preset date. For public entities, this guidance is effective for years beginning after December 15, 2018, including interim periods within those years. The Company adopted the update on January 1, 2019 with no impact on the Company’s consolidated financial statements because Atlas’ callable debt securities, that are held at a premium, are amortized to the earliest call date, which is consistent with current accounting treatment.

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2019
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Schedule of Finite-Lived Intangible Assets	Intangible Assets by Major Asset Class ($ in ‘000s) Economic Useful Life Gross Carrying Amount Accumulated Amortization Net As of September 30, 2019 Trade name and trademark 15 years $ 1,800 $ 551 $ 1,249 Customer relationship 10 years 2,700 1,227 1,473 State insurance licenses Indefinite 740 — 740 $ 5,240 $ 1,778 $ 3,462 As of December 31, 2018 Trade name and trademark 15 years $ 1,800 $ 459 $ 1,341 Customer relationship 10 years 2,700 1,026 1,674 State insurance licenses Indefinite 740 — 740 $ 5,240 $ 1,485 $ 3,755
Schedule of Indefinite-Lived Intangible Assets	Intangible Assets by Major Asset Class ($ in ‘000s) Economic Useful Life Gross Carrying Amount Accumulated Amortization Net As of September 30, 2019 Trade name and trademark 15 years $ 1,800 $ 551 $ 1,249 Customer relationship 10 years 2,700 1,227 1,473 State insurance licenses Indefinite 740 — 740 $ 5,240 $ 1,778 $ 3,462 As of December 31, 2018 Trade name and trademark 15 years $ 1,800 $ 459 $ 1,341 Customer relationship 10 years 2,700 1,026 1,674 State insurance licenses Indefinite 740 — 740 $ 5,240 $ 1,485 $ 3,755

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Computations of Basic and Diluted Earnings per Common Share ($ in ‘000s, except share and per share amounts) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Basic (Loss) income from operations before income taxes $ (2,216 ) $ 7,123 $ (6,168 ) $ 21,014 Income tax expense 26 1,518 26 4,304 Net (loss) income attributable to common shareholders $ (2,242 ) $ 5,605 $ (6,194 ) $ 16,710 Basic weighted average common shares outstanding 11,954,494 11,936,970 11,954,494 12,014,817 Earnings per common share basic $ (0.19 ) $ 0.47 $ (0.52 ) $ 1.39 Diluted Basic weighted average common shares outstanding 11,954,494 11,936,970 11,954,494 12,014,817 Dilutive potential ordinary shares: Dilutive stock options outstanding — 14,247 — 16,921 Diluted weighted average common shares outstanding 11,954,494 11,951,217 11,954,494 12,031,738 Earnings per common share diluted $ (0.19 ) $ 0.47 $ (0.52 ) $ 1.39

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2019
Investments [Abstract]
Schedule of Available-for-sale Securities	Cost or Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments ($ in ‘000s) Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value September 30, 2019 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 22,438 $ 203 $ (41 ) $ 22,600 States, municipalities and political subdivisions 3,904 98 (3 ) 3,999 Corporate Banking/financial services 5,059 124 — 5,183 Consumer goods 2,397 34 (1 ) 2,430 Capital goods 1,152 57 — 1,209 Energy 1,987 76 — 2,063 Telecommunications/utilities 4,215 91 (4 ) 4,302 Health care 499 3 (70 ) 432 Total corporate 15,309 385 (75 ) 15,619 Mortgage-backed Agency 11,136 116 (49 ) 11,203 Commercial 12,642 279 (42 ) 12,879 Total mortgage-backed 23,778 395 (91 ) 24,082 Other asset-backed 11,995 69 (1 ) 12,063 Total fixed income securities $ 77,424 $ 1,150 $ (211 ) $ 78,363 December 31, 2018 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 20,522 $ 30 $ (356 ) $ 20,196 States, municipalities and political subdivisions 8,970 19 (146 ) 8,843 Corporate Banking/financial services 13,482 9 (367 ) 13,124 Consumer goods 10,108 1 (319 ) 9,790 Capital goods 3,711 36 (200 ) 3,547 Energy 7,191 — (379 ) 6,812 Telecommunications/utilities 8,647 1 (325 ) 8,323 Health care 832 — (77 ) 755 Total corporate 43,971 47 (1,667 ) 42,351 Mortgage-backed Agency 25,778 6 (656 ) 25,128 Commercial 20,091 105 (574 ) 19,622 Total mortgage-backed 45,869 111 (1,230 ) 44,750 Other asset-backed 13,881 13 (43 ) 13,851 Total fixed income securities $ 133,213 $ 220 $ (3,442 ) $ 129,991
Summary of Carrying Amounts of Fixed Income Securities, by Contractual Maturity	Amortized Cost and Fair Value of Fixed Income Securities by Contractual Maturity ($ in ‘000s) Amortized Cost Fair Value As of September 30, 2019 One year or less $ 5,396 $ 5,390 One to five years 25,814 26,038 Five to ten years 9,509 9,816 More than ten years 932 974 Total contractual maturity 41,651 42,218 Total mortgage and asset backed 35,773 36,145 Total $ 77,424 $ 78,363
Schedule of Unrealized Loss on Investments	Aging of Unrealized Losses in Fixed Income Securities ($ in ‘000s) Less Than 12 Months More Than 12 Months Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses September 30, 2019 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 3,283 $ (18 ) $ 5,303 $ (23 ) $ 8,586 $ (41 ) States, municipalities and political subdivisions — — 507 (3 ) 507 (3 ) Corporate Banking/financial services 220 — — — 220 — Consumer goods 119 — 263 (1 ) 382 (1 ) Telecommunications/utilities 303 — 184 (4 ) 487 (4 ) Health care — — 299 (70 ) 299 (70 ) Total corporate 642 — 746 (75 ) 1,388 (75 ) Mortgage-backed Agency 1,165 (7 ) 3,538 (42 ) 4,703 (49 ) Commercial 1,152 (6 ) 2,754 (36 ) 3,906 (42 ) Total mortgage-backed 2,317 (13 ) 6,292 (78 ) 8,609 (91 ) Other asset-backed 223 — 204 (1 ) 427 (1 ) Total fixed income securities $ 6,465 $ (31 ) $ 13,052 $ (180 ) $ 19,517 $ (211 ) December 31, 2018 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 507 $ — $ 15,857 $ (356 ) $ 16,364 $ (356 ) States, municipalities and political subdivisions 1,687 (27 ) 4,875 (119 ) 6,562 (146 ) Corporate Banking/financial services 8,376 (235 ) 3,861 (132 ) 12,237 (367 ) Consumer goods 5,442 (176 ) 4,132 (143 ) 9,574 (319 ) Capital goods 1,727 (135 ) 1,430 (65 ) 3,157 (200 ) Energy 4,516 (295 ) 2,296 (84 ) 6,812 (379 ) Telecommunications/utilities 3,806 (99 ) 4,259 (226 ) 8,065 (325 ) Health care 127 (2 ) 628 (75 ) 755 (77 ) Total corporate 23,994 (942 ) 16,606 (725 ) 40,600 (1,667 ) Mortgage-backed Agency 5,035 (72 ) 19,210 (584 ) 24,245 (656 ) Commercial 5,256 (149 ) 11,062 (425 ) 16,318 (574 ) Total mortgage-backed 10,291 (221 ) 30,272 (1,009 ) 40,563 (1,230 ) Other asset-backed 9,568 (22 ) 1,748 (21 ) 11,316 (43 ) Total fixed income securities $ 46,047 $ (1,212 ) $ 69,358 $ (2,230 ) $ 115,405 $ (3,442 )
Summary of Components of Net Investment Income	Components of Net Investment Income ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Total investment income: Interest income $ 686 $ 1,006 $ 2,448 $ 3,139 Income from other investments 32 326 782 793 Investment expenses (290 ) (262 ) (950 ) (731 ) Net investment income $ 428 $ 1,070 $ 2,280 $ 3,201
Schedule of Realized Gain (Loss)	Aggregate Proceeds and Gross Realized Investment Gains and Losses ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Fixed income securities: Proceeds from sales and calls $ 13,520 $ 7,905 $ 53,174 $ 44,262 Gross realized investment gains 169 27 548 280 Gross realized investment losses (54 ) (82 ) (352 ) (539 ) Equities: Proceeds from sales $ — $ 524 $ 5,997 $ 5,373 Gross realized investment gains — 94 443 730 Gross realized investment losses — — (96 ) (26 ) Other investments: Proceeds from sales $ 1,700 $ 15 $ 3,997 $ 56 Gross realized investment gains 298 15 576 56 Total: Proceeds from sales and calls $ 15,220 $ 8,444 $ 63,168 $ 49,691 Gross realized investment gains 467 136 1,567 1,066 Gross realized investment losses (54 ) (82 ) (448 ) (565 ) Components of Net Realized Gains (Losses) ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Fixed income securities $ 115 $ (55 ) $ 196 $ (259 ) Equities — 94 347 704 Other investments 296 15 548 56 Net realized gains $ 411 $ 54 $ 1,091 $ 501
Summary of Components of Net Investment Realized Gains	Components of Net Realized Gains (Losses) ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Fixed income securities $ 115 $ (55 ) $ 196 $ (259 ) Equities — 94 347 704 Other investments 296 15 548 56 Net realized gains $ 411 $ 54 $ 1,091 $ 501
Equity Method Investments by Type	Equity Method Investments by Type ($ in ‘000s) Unfunded Commitments Carrying Value September 30, 2019 September 30, 2019 December 31, 2018 Real estate $ 2,887 $ 11,063 $ 11,085 Insurance linked securities — 1,378 6,694 Activist hedge funds — 3,920 3,911 Venture capital 2,390 2,682 2,015 Other joint venture — 325 325 Total equity method investments $ 5,277 $ 19,368 $ 24,030

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Summary of Investments at Fair Value	Investments at Fair Value ($ in ‘000s) Level 1 Level 2 Level 3 Total As of September 30, 2019 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 22,600 $ — $ — $ 22,600 States, municipalities and political subdivisions — 3,999 — 3,999 Corporate Banking/financial services — 5,183 — 5,183 Consumer goods — 2,430 — 2,430 Capital goods — 1,209 — 1,209 Energy — 2,063 — 2,063 Telecommunications/utilities — 4,302 — 4,302 Health care — 432 — 432 Total corporate — 15,619 — 15,619 Mortgage-backed Agency — 11,203 — 11,203 Commercial — 12,879 — 12,879 Total mortgage-backed — 24,082 — 24,082 Other asset-backed — 12,063 — 12,063 Total fixed income securities $ 22,600 $ 55,763 $ — $ 78,363 Equities 1 — — 1 Total $ 22,601 $ 55,763 $ — $ 78,364 As of December 31, 2018 Fixed income securities: U.S. Treasury and other U.S. government obligations $ 20,196 $ — $ — $ 20,196 States, municipalities and political subdivisions — 8,843 — 8,843 Corporate Banking/financial services — 13,124 — 13,124 Consumer goods — 9,790 — 9,790 Capital goods — 3,547 — 3,547 Energy — 6,812 — 6,812 Telecommunications/utilities — 8,323 — 8,323 Health care — 755 — 755 Total corporate — 42,351 — 42,351 Mortgage-backed Agency — 25,128 — 25,128 Commercial — 19,622 — 19,622 Total mortgage-backed — 44,750 — 44,750 Other asset-backed — 13,851 — 13,851 Total fixed income securities $ 20,196 $ 109,795 $ — $ 129,991 Equities 5,929 — — 5,929 Total $ 26,125 $ 109,795 $ — $ 135,920

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation	Reconciliation of U.S. Statutory Marginal Income Tax Rate to the Effective Tax Rate ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Amount % Amount % Amount % Amount % Provision for taxes at U.S. statutory marginal income tax rate $ (465 ) 21.0 % $ 1,496 21.0 % $ (1,295 ) 21.0 % $ 4,413 21.0 % Provision for deferred tax assets deemed unrealizable (valuation allowance) 469 (21.2 ) — — 1,246 (20.2 ) — — Nondeductible expenses 2 (0.1 ) 25 0.3 27 (0.5 ) 53 0.2 Tax-exempt income (1 ) — (3 ) — (4 ) 0.1 (9 ) — State tax (net of federal benefit) 21 (0.9 ) — — 21 (0.3 ) (2 ) — Stock compensation — — — — 31 (0.5 ) (42 ) (0.2 ) Nondeductible acquisition accounting adjustment — — — — — — (109 ) (0.5 ) Provision for income taxes for continuing operations $ 26 (1.2 )% $ 1,518 21.3 % $ 26 (0.4 )% $ 4,304 20.5 %
Schedule of Components of Income Tax Expense (Benefit)	Components of Income Tax Expense (Benefit) ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Current tax expense (benefit) $ 26 $ (145 ) $ 26 $ (441 ) Deferred tax (benefit) expense (469 ) 1,663 (1,246 ) 4,745 Change in deferred tax valuation allowance 469 — 1,246 — Total $ 26 $ 1,518 $ 26 $ 4,304
Schedule of Deferred Tax Assets and Liabilities	Components of Deferred Income Tax Assets and Liabilities ($ in ‘000s) September 30, 2019 December 31, 2018 Gross deferred tax assets: Losses carried forward $ 27,321 $ 25,326 Claims liabilities and unearned premium reserves 4,352 5,949 Bad debts 1,195 1,009 Stock compensation 834 760 Other 228 418 Valuation allowance (29,788 ) (29,416 ) Total gross deferred tax assets 4,142 4,046 Gross deferred tax liabilities: Deferred policy acquisition costs 1,011 1,535 Investments 1,088 189 Fixed assets 1,258 1,371 Intangible assets 572 633 Other 213 318 Total gross deferred tax liabilities 4,142 4,046 Net deferred tax assets $ — $ —
Summary of Operating Loss Carryforwards	Net Operating Loss Carryforward as of September 30, 2019 by Expiry ($ in ‘000s) Year of Occurrence Year of Expiration Amount 2001 2021 $ 5,007 2002 2022 4,317 2006 2026 7,825 2007 2027 5,131 2008 2028 1,949 2009 2029 1,949 2010 2030 1,949 2011 2031 4,166 2012 2032 9,236 2015 2035 1 2017 2037 27,313 2018 2038 47,653 2018 Indefinite 4,106 2019 2039 4,957 2019 Indefinite 4,543 Total $ 130,102

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property and Equipment Held 1 ($ in ‘000s) September 30, 2019 December 31, 2018 Buildings $ 7,425 $ 7,425 Land 1,840 1,840 Building improvements 9,023 9,006 Leasehold improvements 193 190 Internal use software 20,207 17,575 Computer equipment 1,923 1,821 Furniture and other office equipment 2,897 2,897 Total $ 43,508 $ 40,754 Accumulated depreciation (12,778 ) (9,391 ) Total property and equipment, net $ 30,730 $ 31,363

Reinsurance Ceded (Tables)

Reinsurance Ceded (Tables)	9 Months Ended
	Sep. 30, 2019
Underwriting Policy and Reinsurance Ceded [Abstract]
Schedule of Effects of Reinsurance	Premiums Written, Premiums Earned and Amounts Related to Reinsurance ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Direct premiums written $ 30,728 $ 67,849 $ 160,529 $ 204,697 Assumed premiums written 4,478 8,068 27,319 24,168 Ceded premiums written (13,521 ) (27,756 ) (83,796 ) (63,753 ) Net premiums written $ 21,685 $ 48,161 $ 104,052 $ 165,112 Direct premiums earned $ 57,357 $ 65,519 $ 182,581 $ 192,497 Assumed premiums earned 9,692 6,113 27,371 15,048 Ceded premiums earned (26,467 ) (17,171 ) (78,080 ) (41,833 ) Net premiums earned $ 40,582 $ 54,461 $ 131,872 $ 165,712 Ceded claims and claims adjustment expenses $ 16,140 $ 16,420 $ 45,229 $ 28,449 Ceding commissions 5,308 3,427 19,557 11,421

Claims Liabilities (Tables)

Claims Liabilities (Tables)	9 Months Ended
	Sep. 30, 2019
Insurance Loss Reserves [Abstract]
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense	Changes in the Provision for Unpaid Claims and Claims Adjustment Expenses, Net of Reinsurance Recoverables ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Unpaid claims and claims adjustment expenses, beginning of period $ 252,670 $ 187,170 $ 273,496 $ 211,648 Less: reinsurance recoverable 72,229 46,614 68,771 53,402 Net unpaid claims and claims adjustment expenses, beginning of period 180,441 140,556 204,725 158,246 Incurred related to: Current year 27,601 33,621 93,935 101,109 Prior years 1,240 (79 ) 2,532 1,288 28,841 33,542 96,467 102,397 Paid related to: Current year 12,739 15,639 29,002 36,439 Prior years 31,682 26,563 107,329 92,308 44,421 42,202 136,331 128,747 Net unpaid claims and claims adjustment expenses, end of period 164,861 131,896 164,861 131,896 Add: reinsurance recoverable 79,105 55,085 79,105 55,085 Unpaid claims and claims adjustment expenses, end of period $ 243,966 $ 186,981 $ 243,966 $ 186,981

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Stock Option Activity	Stock Option Activity (prices in Canadian dollars designated with “C$” and U.S. dollars designated with “US$” Nine months ended September 30, 2019 2018 Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price C$ Denominated: Outstanding, beginning of period 27,195 C$6.00 54,390 C$6.00 Granted — — — — Exercised — — (27,195 ) C$6.00 Outstanding, end of period 27,195 C$6.00 27,195 C$6.00 US$ Denominated: Outstanding, beginning of period 375,000 US$17.01 375,000 US$17.01 Granted — — — — Exercised — — — — Outstanding, end of period 375,000 US$17.01 375,000 US$17.01
Schedule of Restricted Stock and Restricted Stock Units Activity	Restricted Stock Grants for Ordinary Voting Common Shares and Restricted Share Unit Activity Nine months ended September 30, 2019 2018 Number of Shares Weighted Average Fair Value at Grant Date Number of Shares Weighted Average Fair Value at Grant Date Non-vested, beginning of period 207,156 $ 16.50 234,080 $ 16.15 Granted — — — — Vested (28,066 ) 11.79 (44,448 ) 12.20 Canceled (7,408 ) 12.20 — — Non-vested, end of period 171,682 $ 17.46 189,632 $ 17.08

Share Capital and Mezzanine E_2

Share Capital and Mezzanine Equity (Tables)	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Schedule of Stock by Class	Share Capital Activity September 30, 2019 December 31, 2018 Shares Authorized Shares Issued Shares Outstanding Amount ($ in ‘000s) Shares Issued Shares Outstanding Amount ($ in ‘000s) Ordinary voting common shares 266,666,667 12,198,319 11,942,812 $ 36 12,192,475 11,936,970 $ 36 Restricted voting common shares 33,333,334 — — — — — — Total common shares 300,000,001 12,198,319 11,942,812 $ 36 12,192,475 11,936,970 $ 36

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs (Tables)	9 Months Ended
	Sep. 30, 2019
Deferred Policy Acquisition Costs Disclosures [Abstract]
Deferred Policy Acquisition Costs Roll Forward	Components of Deferred Policy Acquisition Costs ($ in ‘000s) Nine months ended September 30, 2019 2018 Balance, beginning of period $ 7,309 $ 14,797 Acquisition costs deferred 7,466 13,954 Amortization charged to income (9,960 ) (18,357 ) Balance, end of period $ 4,815 $ 10,394

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Lease, Cost	Lease Expense ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2019 Operating leases $ 242 $ 720 Variable lease cost 90 256 Total $ 332 $ 976 Other Operating Lease Information ($ in ‘000s) Three months ended September 30, Nine months ended September 30, 2019 2019 Cash paid for amounts included in the measurement of lease liabilities reported in operating cash flows $ 333 $ 977 Right-of-use assets obtained in exchange for new lease liabilities 54 54 Total $ 387 $ 1,031 Weighted-average remaining lease term 2.3 years Weighted-average discount rate 3.7 %
Lessee, Operating Lease, Liability, Maturity	The following table presents the undiscounted contractual maturities of the Company’s operating lease liability: Contractual Operating Lease Liabilities ($ in ‘000s) As of September 30, 2019 Remainder of 2019 $ 289 2020 1,103 2021 966 2022 181 2023 15 Total lease payments $ 2,554 Impact of discounting (80 ) Operating lease liability $ 2,474

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Summary of Outstanding Debt	Notes Payable Outstanding ($ in ‘000s) September 30, 2019 December 31, 2018 6.625% Senior Unsecured Notes due April 26, 2022 $ 25,000 $ 25,000 Unamortized issuance costs (577 ) (745 ) Total notes payable $ 24,423 $ 24,255

Statutory Information (Tables)

Statutory Information (Tables)	9 Months Ended
	Sep. 30, 2019
Statutory Information [Abstract]
Statutory Accounting Practices Disclosure	Statutory Net Loss and Surplus of Atlas’ Insurance Subsidiaries ($ in ‘000s) September 30, 2019 December 31, 2018 Net income (loss) computed under statutory-basis accounting $ 8,097 $ (49,648 ) Combined statutory capital and surplus $ 5,496 $ 14,377

Nature of Operations and Basi_3

Nature of Operations and Basis of Presentation (Details)	9 Months Ended
	Sep. 30, 2019statesegment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of states licensed to write property and casualty insurance (state)	49
Number of states, core products actively distributed (state)	42
Number of business segments (segment) | segment	1

New Accounting Standards (Detai

New Accounting Standards (Details) - USD ($)	Sep. 30, 2019	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, liability	$ 2,474,000
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, right-of-use asset		$ 2,600,000
Operating lease, liability		$ 3,200,000

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Schedule of Intangible Assets [Line Items]
Intangible assets, accumulated amortization	$ 1,778	$ 1,485
Intangible assets, gross (excluding goodwill)	5,240	5,240
Intangible assets, net	3,462	3,755
State insurance licenses
Schedule of Intangible Assets [Line Items]
Indefinite-lived intangible assets (excluding goodwill)	$ 740	$ 740
Trade names and trademarks
Schedule of Intangible Assets [Line Items]
Finite-lived intangible asset, economic useful life	15 years	15 years
Finite-lived intangible assets, gross carrying amount	$ 1,800	$ 1,800
Intangible assets, accumulated amortization	551	459
Finite-lived intangible assets, net	$ 1,249	$ 1,341
Customer relationships
Schedule of Intangible Assets [Line Items]
Finite-lived intangible asset, economic useful life	10 years	10 years
Finite-lived intangible assets, gross carrying amount	$ 2,700	$ 2,700
Intangible assets, accumulated amortization	1,227	1,026
Finite-lived intangible assets, net	$ 1,473	$ 1,674

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Earnings Per Share [Abstract]
(Loss) income from operations before income taxes	$ (2,216)	$ 7,123	$ (6,168)	$ 21,014
Income tax expense	26	1,518	26	4,304
Net (loss) income	$ (2,242)	$ 5,605	$ (6,194)	$ 16,710
Basic:
Basic weighted average common shares outstanding (in shares)	11,954,494	11,936,970	11,954,494	12,014,817
Earnings per common share basic (in dollars per share)	$ (0.19)	$ 0.47	$ (0.52)	$ 1.39
Diluted:
Basic weighted average common shares outstanding (in shares)	11,954,494	11,936,970	11,954,494	12,014,817
Dilutive stock options outstanding (in shares)	0	14,247	0	16,921
Diluted weighted average common shares outstanding (includes RSUs) (in shares)	11,954,494	11,951,217	11,954,494	12,031,738
Earnings per common share diluted (in dollars per share)	$ (0.19)	$ 0.47	$ (0.52)	$ 1.39

Investments - Schedule of Avail

Investments - Schedule of Available-for-Sale Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	$ 77,424	$ 133,213
Fixed income securities	78,363	129,991
Fixed Income Securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	77,424	133,213
Gross Unrealized Gains	1,150	220
Gross Unrealized Losses	(211)	(3,442)
Fixed income securities	78,363	129,991
US Government Agencies Debt Securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	22,438	20,522
Gross Unrealized Gains	203	30
Gross Unrealized Losses	(41)	(356)
Fixed income securities	22,600	20,196
US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	3,904	8,970
Gross Unrealized Gains	98	19
Gross Unrealized Losses	(3)	(146)
Fixed income securities	3,999	8,843
Total corporate
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	15,309	43,971
Gross Unrealized Gains	385	47
Gross Unrealized Losses	(75)	(1,667)
Fixed income securities	15,619	42,351
Corporate Debt Securities, Banking and Financial Services
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	5,059	13,482
Gross Unrealized Gains	124	9
Gross Unrealized Losses	0	(367)
Fixed income securities	5,183	13,124
Corporate Debt Securities, Consumer Goods
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	2,397	10,108
Gross Unrealized Gains	34	1
Gross Unrealized Losses	(1)	(319)
Fixed income securities	2,430	9,790
Corporate Debt Securities, Capital Goods
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	1,152	3,711
Gross Unrealized Gains	57	36
Gross Unrealized Losses	0	(200)
Fixed income securities	1,209	3,547
Corporate Debt Securities, Energy
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	1,987	7,191
Gross Unrealized Gains	76	0
Gross Unrealized Losses	0	(379)
Fixed income securities	2,063	6,812
Corporate Debt Securities, Telecommunications and Utilities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	4,215	8,647
Gross Unrealized Gains	91	1
Gross Unrealized Losses	(4)	(325)
Fixed income securities	4,302	8,323
Corporate Debt Securities, Health Care
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	499	832
Gross Unrealized Gains	3	0
Gross Unrealized Losses	(70)	(77)
Fixed income securities	432	755
Total Mortgage Backed
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	23,778	45,869
Gross Unrealized Gains	395	111
Gross Unrealized Losses	(91)	(1,230)
Fixed income securities	24,082	44,750
Fixed Income, U.S., Mortgage Backed, Agency
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	11,136	25,778
Gross Unrealized Gains	116	6
Gross Unrealized Losses	(49)	(656)
Fixed income securities	11,203	25,128
Commercial Mortgage Backed Securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	12,642	20,091
Gross Unrealized Gains	279	105
Gross Unrealized Losses	(42)	(574)
Fixed income securities	12,879	19,622
Asset-backed Securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale debt securities, amortized cost basis	11,995	13,881
Gross Unrealized Gains	69	13
Gross Unrealized Losses	(1)	(43)
Fixed income securities	$ 12,063	$ 13,851

Investments - Classified by Con

Investments - Classified by Contractual Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Investments [Abstract]
Available-for-sale securities, debt maturities, rolling twelve months, amortized cost	$ 5,396
Available-for-sale securities, debt maturities, rolling year two through five, amortized cost	25,814
Available-for-sale securities, debt maturities, rolling year six through ten, amortized cost	9,509
Available-for-sale securities, debt maturities, rolling after year ten, amortized cost	932
Available-for-sale securities, debt maturities, single maturity date, amortized cost	41,651
Available-for-sale securities, debt maturities, without single maturity date, amortized cost	35,773
Available-for-sale debt securities, amortized cost basis	77,424	$ 133,213
Available-for-sale securities, debt maturities, next twelve months, fair value	5,390
Available-for-sale securities, debt maturities, rolling year two through five, fair value	26,038
Available-for-sale securities, debt maturities, rolling year six through ten, fair value	9,816
Available-for-sale securities, debt maturities, rolling after year ten, fair value	974
Available-for-sale Securities, debt maturities, single maturity date, fair value	42,218
Available-for-sale securities, debt maturities, without single maturity date, fair value	36,145
Available-for-sale securities, debt securities	$ 78,363	$ 129,991

Investments - Analysis of Inves

Investments - Analysis of Investments (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Investments [Abstract]
Other than temporary impairment losses, investments	$ 0	$ 0	$ 0	$ 0

Investments - Unrealized Losses

Investments - Unrealized Losses (Details) $ in Thousands	Sep. 30, 2019USD ($)security	Dec. 31, 2018USD ($)security
Fixed Income Securities
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	$ 6,465	$ 46,047
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	(31)	(1,212)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	13,052	69,358
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(180)	(2,230)
Debt securities, available-for-sale, unrealized loss position, fair value	19,517	115,405
Debt securities, available-for-sale, unrealized loss position, accumulated loss	$ (211)	$ (3,442)
Available-for-sale, securities in unrealized loss positions, qualitative disclosure, number of positions | security	75	391
Available-for-sale, securities in unrealized loss positions, qualitative disclosure, number of positions, greater than or equal to one year | security	50	246
US Government Agencies Debt Securities
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	$ 3,283	$ 507
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	(18)	0
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	5,303	15,857
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(23)	(356)
Debt securities, available-for-sale, unrealized loss position, fair value	8,586	16,364
Debt securities, available-for-sale, unrealized loss position, accumulated loss	(41)	(356)
US States and Political Subdivisions Debt Securities
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	0	1,687
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	0	(27)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	507	4,875
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(3)	(119)
Debt securities, available-for-sale, unrealized loss position, fair value	507	6,562
Debt securities, available-for-sale, unrealized loss position, accumulated loss	(3)	(146)
Total corporate
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	642	23,994
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	0	(942)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	746	16,606
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(75)	(725)
Debt securities, available-for-sale, unrealized loss position, fair value	1,388	40,600
Debt securities, available-for-sale, unrealized loss position, accumulated loss	(75)	(1,667)
Corporate Debt Securities, Banking and Financial Services
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	220	8,376
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	0	(235)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	0	3,861
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	0	(132)
Debt securities, available-for-sale, unrealized loss position, fair value	220	12,237
Debt securities, available-for-sale, unrealized loss position, accumulated loss	0	(367)
Corporate Debt Securities, Consumer Goods
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	119	5,442
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	0	(176)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	263	4,132
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(1)	(143)
Debt securities, available-for-sale, unrealized loss position, fair value	382	9,574
Debt securities, available-for-sale, unrealized loss position, accumulated loss	(1)	(319)
Corporate Debt Securities, Capital Goods
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value		1,727
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss		(135)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value		1,430
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss		(65)
Debt securities, available-for-sale, unrealized loss position, fair value		3,157
Debt securities, available-for-sale, unrealized loss position, accumulated loss		(200)
Corporate Debt Securities, Energy
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value		4,516
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss		(295)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value		2,296
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss		(84)
Debt securities, available-for-sale, unrealized loss position, fair value		6,812
Debt securities, available-for-sale, unrealized loss position, accumulated loss		(379)
Corporate Debt Securities, Telecommunications and Utilities
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	303	3,806
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	0	(99)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	184	4,259
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(4)	(226)
Debt securities, available-for-sale, unrealized loss position, fair value	487	8,065
Debt securities, available-for-sale, unrealized loss position, accumulated loss	(4)	(325)
Corporate Debt Securities, Health Care
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	0	127
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	0	(2)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	299	628
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(70)	(75)
Debt securities, available-for-sale, unrealized loss position, fair value	299	755
Debt securities, available-for-sale, unrealized loss position, accumulated loss	(70)	(77)
Total Mortgage Backed
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	2,317	10,291
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	(13)	(221)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	6,292	30,272
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(78)	(1,009)
Debt securities, available-for-sale, unrealized loss position, fair value	8,609	40,563
Debt securities, available-for-sale, unrealized loss position, accumulated loss	(91)	(1,230)
Fixed Income, U.S., Mortgage Backed, Agency
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	1,165	5,035
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	(7)	(72)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	3,538	19,210
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(42)	(584)
Debt securities, available-for-sale, unrealized loss position, fair value	4,703	24,245
Debt securities, available-for-sale, unrealized loss position, accumulated loss	(49)	(656)
Commercial Mortgage Backed Securities
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	1,152	5,256
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	(6)	(149)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	2,754	11,062
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(36)	(425)
Debt securities, available-for-sale, unrealized loss position, fair value	3,906	16,318
Debt securities, available-for-sale, unrealized loss position, accumulated loss	(42)	(574)
Asset-backed Securities
Aging of Unrealized Losses [Line Items]
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 Months, fair value	223	9,568
Debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss	0	(22)
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, fair value	204	1,748
Debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss	(1)	(21)
Debt securities, available-for-sale, unrealized loss position, fair value	427	11,316
Debt securities, available-for-sale, unrealized loss position, accumulated loss	$ (1)	$ (43)

Investments - Schedule of Inves

Investments - Schedule of Investment Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Investments [Abstract]
Interest income	$ 686	$ 1,006	$ 2,448	$ 3,139
Income from other investments	32	326	782	793
Investment expenses	(290)	(262)	(950)	(731)
Net investment income	$ 428	$ 1,070	$ 2,280	$ 3,201

Investments - Schedule of Gross

Investments - Schedule of Gross Realized Gains (Losses) on Sales (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Debt Securities, Available-for-sale [Line Items]
Proceeds from sales and calls	$ 15,220	$ 8,444	$ 63,168	$ 49,691
Gross realized investment gains	467	136	1,567	1,066
Gross realized investment losses	(54)	(82)	(448)	(565)
Fixed income securities
Debt Securities, Available-for-sale [Line Items]
Proceeds from sales and calls	13,520	7,905	53,174	44,262
Gross realized investment gains	169	27	548	280
Gross realized investment losses	(54)	(82)	(352)	(539)
Equity Securities
Debt Securities, Available-for-sale [Line Items]
Proceeds from sales and calls	0	524	5,997	5,373
Gross realized investment gains	0	94	443	730
Gross realized investment losses	0	0	(96)	(26)
Other Investments
Debt Securities, Available-for-sale [Line Items]
Proceeds from sales and calls	1,700	15	3,997	56
Gross realized investment gains	$ 298	$ 15	$ 576	$ 56

Investments - Schedule of Inv_2

Investments - Schedule of Investment Gains (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Gain (Loss) on Securities [Line Items]
Net realized gains (losses)	$ 411	$ 54	$ 1,091	$ 501
Other Investments
Gain (Loss) on Securities [Line Items]
Net realized gains (losses)	296	15	548	56
Fixed income securities
Gain (Loss) on Securities [Line Items]
Net realized gains (losses)	115	(55)	196	(259)
Equities
Gain (Loss) on Securities [Line Items]
Net realized gains (losses)	$ 0	$ 94	$ 347	$ 704

Investments - Equity Method Inv

Investments - Equity Method Investment, By Type (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]
Unfunded commitments	$ 5,277
Equity method limited partnership	19,368	$ 24,030
Real estate
Schedule of Equity Method Investments [Line Items]
Unfunded commitments	2,887
Equity method limited partnership	11,063	11,085
Insurance linked securities
Schedule of Equity Method Investments [Line Items]
Unfunded commitments	0
Equity method limited partnership	1,378	6,694
Activist hedge funds
Schedule of Equity Method Investments [Line Items]
Unfunded commitments	0
Equity method limited partnership	3,920	3,911
Venture capital
Schedule of Equity Method Investments [Line Items]
Unfunded commitments	2,390
Equity method limited partnership	2,682	2,015
Other joint venture
Schedule of Equity Method Investments [Line Items]
Unfunded commitments	0
Equity method limited partnership	$ 325	$ 325

Investments - Other Investments

Investments - Other Investments (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Investments [Abstract]
Equity method limited partnership	$ 19,368,000	$ 24,030,000
Financing receivable, recorded investment, current	93,000	1,000,000
Financing Receivable, Allowance for Credit Losses [Line Items]
Short-term investments	8,562,000	4,745,000
Other Investments
Financing Receivable, Allowance for Credit Losses [Line Items]
Valuation allowance	$ 0	$ 0

Investments - Collateral Pledge

Investments - Collateral Pledged (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Investments [Abstract]
Bonds and term deposits, fair value	$ 16.9	$ 14.9
Securities pledged as collateral	$ 49.4	$ 31.3

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Assets Measured at Fair Value on Recurring and Nonrecurring Basis (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	$ 78,363,000		$ 78,363,000		$ 129,991,000
Equities	1,000		1,000		5,929,000
Fair value, available-for-sale securities	78,364,000		78,364,000		135,920,000
Fair value, assets, Level 1 to Level 2 transfers, amount	0	$ 0	0	$ 0
Fair value, assets, Level 2 to Level 1 transfers, amount	0	0	0	0
Fair value, asset transfers into Level 3	0	0	0	0
Fair value, asset transfers out of Level 3	0	$ 0	0	$ 0
US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	22,600,000		22,600,000		20,196,000
US States and Political Subdivisions Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	3,999,000		3,999,000		8,843,000
Total corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	15,619,000		15,619,000		42,351,000
Corporate Debt Securities, Banking and Financial Services
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	5,183,000		5,183,000		13,124,000
Corporate Debt Securities, Consumer Goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	2,430,000		2,430,000		9,790,000
Corporate Debt Securities, Capital Goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	1,209,000		1,209,000		3,547,000
Corporate Debt Securities, Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	2,063,000		2,063,000		6,812,000
Corporate Debt Securities, Telecommunications and Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	4,302,000		4,302,000		8,323,000
Corporate Debt Securities, Health Care
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	432,000		432,000		755,000
Total Mortgage Backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	24,082,000		24,082,000		44,750,000
Fixed Income, U.S., Mortgage Backed, Agency
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	11,203,000		11,203,000		25,128,000
Commercial Mortgage Backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	12,879,000		12,879,000		19,622,000
Asset-backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	12,063,000		12,063,000		13,851,000
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	22,600,000		22,600,000		20,196,000
Equities	1,000		1,000		5,929,000
Fair value, available-for-sale securities	22,601,000		22,601,000		26,125,000
Level 1 | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	22,600,000		22,600,000		20,196,000
Level 1 | US States and Political Subdivisions Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Total corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Corporate Debt Securities, Banking and Financial Services
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Corporate Debt Securities, Consumer Goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Corporate Debt Securities, Capital Goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Corporate Debt Securities, Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Corporate Debt Securities, Telecommunications and Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Corporate Debt Securities, Health Care
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Total Mortgage Backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Fixed Income, U.S., Mortgage Backed, Agency
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Commercial Mortgage Backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 1 | Asset-backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	55,763,000		55,763,000		109,795,000
Equities	0		0		0
Fair value, available-for-sale securities	55,763,000		55,763,000		109,795,000
Level 2 | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 2 | US States and Political Subdivisions Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	3,999,000		3,999,000		8,843,000
Level 2 | Total corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	15,619,000		15,619,000		42,351,000
Level 2 | Corporate Debt Securities, Banking and Financial Services
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	5,183,000		5,183,000		13,124,000
Level 2 | Corporate Debt Securities, Consumer Goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	2,430,000		2,430,000		9,790,000
Level 2 | Corporate Debt Securities, Capital Goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	1,209,000		1,209,000		3,547,000
Level 2 | Corporate Debt Securities, Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	2,063,000		2,063,000		6,812,000
Level 2 | Corporate Debt Securities, Telecommunications and Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	4,302,000		4,302,000		8,323,000
Level 2 | Corporate Debt Securities, Health Care
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	432,000		432,000		755,000
Level 2 | Total Mortgage Backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	24,082,000		24,082,000		44,750,000
Level 2 | Fixed Income, U.S., Mortgage Backed, Agency
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	11,203,000		11,203,000		25,128,000
Level 2 | Commercial Mortgage Backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	12,879,000		12,879,000		19,622,000
Level 2 | Asset-backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	12,063,000		12,063,000		13,851,000
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Equities	0		0		0
Fair value, available-for-sale securities	0		0		0
Level 3 | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | US States and Political Subdivisions Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Total corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Corporate Debt Securities, Banking and Financial Services
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Corporate Debt Securities, Consumer Goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Corporate Debt Securities, Capital Goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Corporate Debt Securities, Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Corporate Debt Securities, Telecommunications and Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Corporate Debt Securities, Health Care
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Total Mortgage Backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Fixed Income, U.S., Mortgage Backed, Agency
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Commercial Mortgage Backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	0		0		0
Level 3 | Asset-backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	$ 0		$ 0		$ 0

Income Taxes - Rate Reconciliat

Income Taxes - Rate Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Provision for taxes at U.S. statutory marginal income tax rate	$ (465)	$ 1,496	$ (1,295)	$ 4,413
Provision for deferred tax assets deemed unrealizable (valuation allowance)	469	0	1,246	0
Nondeductible expenses	2	25	27	53
Tax-exempt income	(1)	(3)	(4)	(9)
State tax (net of federal benefit)	21	0	21	(2)
Stock compensation	0	0	31	(42)
Nondeductible acquisition accounting adjustment	0	0	0	(109)
Provision for income taxes for continuing operations	$ 26	$ 1,518	$ 26	$ 4,304
Provision for taxes at U.S. statutory marginal income tax rate, percent	21.00%	21.00%	21.00%	21.00%
Provision for deferred tax assets deemed unrealizable (valuation allowance), percent	(21.20%)	0.00%	(20.20%)	0.00%
Nondeductible expenses, percent	(0.10%)	0.30%	(0.50%)	0.20%
Tax-exempt income, percent	(0.00%)	(0.00%)	0.10%	(0.00%)
State tax (net of federal benefit), percent	(0.90%)	0.00%	(0.30%)	0.00%
Stock compensation, percent	0.00%	0.00%	(0.50%)	(0.20%)
Nondeductible acquisition accounting adjustment, percent	0.00%	0.00%	0.00%	(0.50%)
Effective income tax rate	(1.20%)	21.30%	(0.40%)	20.50%

Income Taxes - Components of In

Income Taxes - Components of Income Tax Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Current tax expense (benefit)	$ 26	$ (145)	$ 26	$ (441)
Deferred tax (benefit) expense	(469)	1,663	(1,246)	4,745
Change in deferred tax valuation allowance	469	0	1,246	0
Provision for income taxes for continuing operations	$ 26	$ 1,518	$ 26	$ 4,304

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Gross deferred tax assets:
Losses carried forward	$ 27,321	$ 25,326
Claims liabilities and unearned premium reserves	4,352	5,949
Bad debts	1,195	1,009
Stock compensation	834	760
Other	228	418
Valuation allowance	(29,788)	(29,416)
Total gross deferred tax assets	4,142	4,046
Gross deferred tax liabilities:
Deferred policy acquisition costs	1,011	1,535
Investments	1,088	189
Fixed assets	1,258	1,371
Intangible assets	572	633
Other	213	318
Total gross deferred tax liabilities	4,142	4,046
Net deferred tax assets	$ 0	$ 0

Income Taxes - Schedule of Tax

Income Taxes - Schedule of Tax Carryforwards (Details) $ in Thousands	Sep. 30, 2019USD ($)
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	$ 130,102
Carryforward Expiring in 2021
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	5,007
Carryforward Expiring in 2022
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	4,317
Carryforward Expiring in 2026
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	7,825
Carryforward Expiring in 2027
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	5,131
Carryforward Expiring in 2028
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	1,949
Carryforward Expiring in 2029
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	1,949
Carryforward Expiring in 2030
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	1,949
Carryforward Expiring in 2031
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	4,166
Carryforward Expiring in 2032
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	9,236
Carryforward Expiring in 2035
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	1
Carryforward Expiring in 2037
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	27,313
Carryforward Expiring in 2038
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	47,653
Carryforward Expiring in 2039
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	4,957
Carryforward Expiring Indefinite
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	4,106
Carryforward Expiring Indefinite Originated In 2019
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	$ 4,543

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Thousands	Sep. 30, 2019USD ($)
Commitments and Contingencies Disclosure [Abstract]
Unfunded commitments	$ 5,277

Property and Equipment (Details

Property and Equipment (Details) ft² in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2019USD ($)ft²	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)ft²	Sep. 30, 2018USD ($)	Dec. 31, 2018USD ($)
Property, Plant and Equipment [Line Items]
Property and equipment gross	$ 43,508,000		$ 43,508,000		$ 40,754,000
Accumulated depreciation	(12,778,000)		(12,778,000)		(9,391,000)
Total property and equipment, net	30,730,000		30,730,000		31,363,000
Depreciation and amortization of property and equipment	$ 1,202,000	$ 696,000	$ 3,387,000	$ 2,061,000	2,900,000
Occupied area of corporate headquarters building | ft²	70		70
Rental Income, Nonoperating	$ 111,000	144,000	$ 334,000	323,000
Capitalized costs			2,700,000
Amortization of capitalized costs	645,000	140,000	1,695,000	420,000
Loss on disposition of fixed assets	2,000	0	28,000	0
Buildings
Property, Plant and Equipment [Line Items]
Property and equipment gross	7,425,000		7,425,000		7,425,000
Land
Property, Plant and Equipment [Line Items]
Property and equipment gross	1,840,000		1,840,000		1,840,000
Building improvements
Property, Plant and Equipment [Line Items]
Property and equipment gross	9,023,000		9,023,000		9,006,000
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment gross	193,000		193,000		190,000
Internal use software
Property, Plant and Equipment [Line Items]
Property and equipment gross	20,207,000		20,207,000		17,575,000
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment gross	1,923,000		1,923,000		1,821,000
Furniture and other office equipment
Property, Plant and Equipment [Line Items]
Property and equipment gross	2,897,000		2,897,000		$ 2,897,000
Building and building improvements
Property, Plant and Equipment [Line Items]
Depreciation and amortization of property and equipment	$ 283,000	$ 277,000	$ 850,000	$ 819,000

Reinsurance Ceded (Details)

Reinsurance Ceded (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Underwriting Policy and Reinsurance Ceded [Abstract]
Direct premiums written	$ 30,728	$ 67,849	$ 160,529	$ 204,697
Assumed premiums written	4,478	8,068	27,319	24,168
Ceded premiums written	(13,521)	(27,756)	(83,796)	(63,753)
Net premiums written	21,685	48,161	104,052	165,112
Direct premiums earned	57,357	65,519	182,581	192,497
Assumed premiums earned	9,692	6,113	27,371	15,048
Ceded premiums earned	(26,467)	(17,171)	(78,080)	(41,833)
Net premiums earned	40,582	54,461	131,872	165,712
Ceded claims and claims adjustment expenses	16,140	16,420	45,229	28,449
Ceding commissions	$ 5,308	$ 3,427	$ 19,557	$ 11,421

- Unpaid Claims (Details)

- Unpaid Claims (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019	Dec. 31, 2018	Jun. 30, 2018	Dec. 31, 2017
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Unpaid claims and claims adjustment expenses, beginning of period	$ 252,670	$ 187,170	$ 273,496	$ 211,648
Less: reinsurance recoverable, beginning of period	72,229	46,614	68,771	53,402
Net unpaid claims and claims adjustment expenses, beginning of period	164,861	131,896	164,861	131,896	$ 180,441	$ 204,725	$ 140,556	$ 158,246
Incurred related to:
Current year	27,601	33,621	93,935	101,109
Prior years	1,240	(79)	2,532	1,288
Total incurred current and prior years	28,841	33,542	96,467	102,397
Paid related to:
Current year	12,739	15,639	29,002	36,439
Prior years	31,682	26,563	107,329	92,308
Total paid current and prior years	44,421	42,202	136,331	128,747
Net unpaid claims and claims adjustment expenses, end of period	164,861	131,896	164,861	131,896
Add: reinsurance recoverable, end of period	79,105	55,085	79,105	55,085
Unpaid claims and claims adjustment expenses, end of period	$ 243,966	$ 186,981	$ 243,966	$ 186,981

Share-Based Compensation - Sche

Share-Based Compensation - Schedule of Outstanding Options and Restricted Shares (Details)	9 Months Ended
	Sep. 30, 2019$ / sharesshares	Sep. 30, 2019$ / sharesshares	Sep. 30, 2018$ / sharesshares	Sep. 30, 2018$ / sharesshares
Prior to December 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Option, outstanding (in shares), beginning of period | shares	27,195	27,195	54,390	54,390
Options, granted in period (in shares) | shares	0	0	0	0
Options, exercised in period (in shares) | shares	0	0	(27,195)	(27,195)
Option, outstanding (in shares), end of period | shares	27,195	27,195	27,195	27,195
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, outstanding, weighted average exercise price beginning balance (in US or Canadian dollars per share) | $ / shares		$ 6		$ 6
Options, granted in period, weighted average exercise price (in US or Canadian dollars per share) | $ / shares		0		0
Options, exercises in period, weighted average exercise price (in US or Canadian dollars per share) | $ / shares		0		6
Options, outstanding, weighted average exercise price, ending balance (in US or Canadian dollars per share) | $ / shares		$ 6		$ 6
After December 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Option, outstanding (in shares), beginning of period | shares	375,000	375,000	375,000	375,000
Options, granted in period (in shares) | shares	0	0	0	0
Options, exercised in period (in shares) | shares	0	0	0	0
Option, outstanding (in shares), end of period | shares	375,000	375,000	375,000	375,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, outstanding, weighted average exercise price beginning balance (in US or Canadian dollars per share) | $ / shares	$ 17.01		$ 17.01
Options, granted in period, weighted average exercise price (in US or Canadian dollars per share) | $ / shares	0		0
Options, exercises in period, weighted average exercise price (in US or Canadian dollars per share) | $ / shares	0		0
Options, outstanding, weighted average exercise price, ending balance (in US or Canadian dollars per share) | $ / shares	$ 17.01		$ 17.01

Share-Based Compensation - Narr

Share-Based Compensation - Narrative (Details)	Dec. 31, 2018	Mar. 12, 2015shares	Feb. 28, 2014shares	Sep. 30, 2019USD ($)shares	Sep. 30, 2018USD ($)shares	Dec. 31, 2013USD ($)	Sep. 30, 2019USD ($)shares	Sep. 30, 2018USD ($)shares	Dec. 31, 2018USD ($)shares	Apr. 04, 2018$ / shares	Jun. 17, 2013$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants, weighted average remaining life							4 years 8 months 23 days
Options outstanding, intrinsic value				$ 0			$ 0
Share-based compensation expense				188,000	$ 285,000		$ 685,000	$ 856,000
Unearned share-based compensation expense, remaining amortization period							8 months
Restricted share and restricted share units grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unearned share-based compensation expense				235,000			$ 235,000
Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price (in dollars per share) | $ / shares											$ 8.10
Equity Incentive Plan | Director | Restricted Stock Grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity Incentive Plan, ratio matching grant of restricted stock for common stock (in shares)						3
Matching shares granted in period (in shares) | shares			148,152
Award vesting rights, percentage			20.00%
Equity Incentive Plan | Director | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Matching shares granted in period (in shares) | shares			37,038
December 31, 2018 | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	33.30%
December 31, 2018 | Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price (in dollars per share) | $ / shares										$ 10.50
December 31, 2018 | Equity Incentive Plan | Director | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferred compensation arrangement with individual, fair value (in shares)									$ 40,000
Restricted shares granted during period (shares) | shares									17,524
Share-based compensation arrangement by share-based payment award, aggregate grant date fair value									$ 179,000
Award vesting period									3 years
March 12, 2015 | Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, non-vested, fair value				1,500,000			1,500,000
March 12, 2015 | Restricted Stock Grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted share awards, non-vested, fair value				$ 1,900,000			$ 1,900,000
March 12, 2015 | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage		20.00%
Award vesting period		5 years
March 12, 2015 | Officer | Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares vested during period (shares) | shares					0		0	0
Options, granted in period (in shares) | shares		200,000
March 12, 2015 | Officer | Restricted Stock Grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares vested during period (shares) | shares				0
Restricted shares granted during period (shares) | shares		200,000
Ordinary Voting Common Shares | Equity Incentive Plan | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity Incentive Plan, threshold by direct or indirect purchase of stock						$ 100,000

Share-Based Compensation - Sc_2

Share-Based Compensation - Schedule of Restricted Shares and Restricted Share Units (Details) - Restricted stock and restricted stock units (RSUs) - $ / shares	9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted shares nonvested at period start (shares)	207,156	234,080	234,080
Restricted shares granted during period (shares)	0	0
Restricted shares vested during period (shares)	(28,066)	(44,448)
Restricted shares canceled during period (shares)	(7,408)	0
Restricted shares nonvested at period end (shares)	171,682	189,632	207,156
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average fair value at grant date, restricted shares nonvested at period start (USD per share)	$ 16.50	$ 16.15	$ 16.15
Weighted average fair value at grant date, restricted shares granted during period (USD per share)	0	0
Weighted average fair value at grant date, restricted shares vested during period (USD per share)	11.79	12.20
Weighted average fair value at grant date, restricted shares vested during period (USD per share)	12.20	0
Weighted average fair value at grant date, restricted shares nonvested at period end (USD per share)	$ 17.46	$ 17.08	$ 16.50

Other Employee Benefit Plans -

Other Employee Benefit Plans - Defined Contribution Plan (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Other Employee Benefit Plans [Abstract]
Defined contribution plan, percent of employee contribution matched by employer, up to 2.5% annual earnings			100.00%
Defined contribution plan, percent of employer match on additional employee contributions, up to 2.5% annual earnings			50.00%
Defined contribution plan employer additional contribution matching percent of employees gross pay			2.50%
Defined contribution plan, percent of additional employees annual earnings employer will match 50%			2.50%
Defined contribution plan, employer matching contribution, maximum percent of employees' gross pay			3.75%
Defined contribution plan, employee contribution vesting percentage			100.00%
Defined contribution plan, employers matching contribution, vesting period			5 years
Defined contribution plan, company contributions	$ 159	$ 139	$ 493	$ 419

Other Employee Benefit Plans _2

Other Employee Benefit Plans - Employee Stock Purchase Plan (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)
Other Employee Benefit Plans [Abstract]
Employee stock purchase plan, hours of week threshold for investing in ordinary voting common shares			30 hours
Employee stock purchase plan, maximum annual contribution percent of annual earnings per employee			0.075
Employee stock purchase plan, percent of employee contribution matched by employer, up to 2.5% annual earnings			1
Employee stock purchase plan, percent of employees annual earnings employer will match 100%			2.50%
Employee stock purchase plan employer additional matching contribution on percent of employees gross pay			50.00%
Employee stock purchase plan, percent of additional employees annual earnings employer will match 50%			5.00%
Employee stock purchase plan, employer matching contribution, maximum percent of employee's gross pay			5.00%
Employee stock purchase plan, company cost	$ 25	$ 64	$ 129	$ 184

Share Capital and Mezzanine E_3

Share Capital and Mezzanine Equity - Schedule of Stock by Class (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	300,000,001
Common stock, shares issued (in shares)	12,198,319	12,192,475
Common stock, shares outstanding (in shares)	11,942,812	11,936,970
Common stock, value, outstanding	$ 36	$ 36
Ordinary Voting Common Shares
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	266,666,667	266,666,667
Common stock, shares issued (in shares)	12,198,319	12,192,475
Common stock, shares outstanding (in shares)	11,942,812	11,936,970
Common stock, value, outstanding	$ 36	$ 36
Restricted Voting Common Shares
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	33,333,334	33,333,334
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0
Common stock, value, outstanding	$ 0	$ 0

Share Capital and Mezzanine E_4

Share Capital and Mezzanine Equity - Narrative (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018	Mar. 21, 2017
Class of Stock [Line Items]
Ordinary voting common shares issued, RSU vesting (in shares)		27,195
Ordinary voting common shares canceled, RSU vesting (in shares)		6,169
Stock repurchase program, number of shares authorized to be repurchased (in shares)			650,000
Treasury stock, shares acquired (in shares)		255,505
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, dividend rate, (USD per share)	$ 0.045
Preferred stock, dividend rate, percentage	4.50%
Preferred stock, liquidation preference per share (USD per share)	$ 1
Preferred dividends in arrears	$ 0	$ 333,000
Restricted Stock Units (RSUs)
Class of Stock [Line Items]
Nonvested restricted stock units (RSUs) (shares)	11,682	24,932
Ordinary voting common shares issued, RSU vesting (in shares)	5,842	7,408

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period			$ 7,309	$ 14,797
Acquisition costs deferred			7,466	13,954
Amortization charged to income	$ (3,248)	$ (5,701)	(9,960)	(18,357)
Balance, end of period	$ 4,815	$ 10,394	$ 4,815	$ 10,394

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($)	Jan. 01, 2019	Sep. 30, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease liability		$ 2,474,000
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right-of-use asset	$ 2,600,000
Operating lease liability	3,200,000
Operating lease, expense	$ 600,000

Leases - Lease Expenses (Detail

Leases - Lease Expenses (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Leases [Abstract]
Operating leases	$ 242,000	$ 720,000
Variable lease cost	90,000	256,000
Lease expense	$ 332,000	$ 976,000

Leases - Other Operating Lease

Leases - Other Operating Lease Information (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2019USD ($)
Leases [Abstract]
Cash paid for amounts included in the measurement of lease liabilities reported in operating cash flows	$ 333,000	$ 977,000
Right-of-use assets obtained in exchange for new lease liabilities	54,000	54,000
Lease expense	$ 387,000	$ 1,031,000
Weighted-average remaining lease term	2 years 3 months 22 days	2 years 3 months 22 days
Weighted-average discount rate	3.70%	3.70%

Leases - Contractual Operating

Leases - Contractual Operating Lease Liability (Details)	Sep. 30, 2019USD ($)
Leases [Abstract]
Remainder of 2019	$ 289,000
2020	1,103,000
2021	966,000
2022	181,000
2023	15,000
Total lease payments	2,554,000
Impact of discounting	(80,000)
Operating lease liability	$ 2,474,000

Related Party Transactions (Det

Related Party Transactions (Details)	Sep. 30, 2019	Dec. 31, 2018
Director or Director Affiliated Entity
Related Party Transaction [Line Items]
Percent of invested assets considered related party transactions	5.70%	5.10%

Notes Payable - Narrative (Deta

Notes Payable - Narrative (Details) - USD ($)	Apr. 26, 2017	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Line of Credit Facility [Line Items]
Interest expense, including non-utilization fees		$ 470,000	$ 465,000	$ 1,400,000	$ 1,400,000
Senior unsecured notes
Line of Credit Facility [Line Items]
Debt instrument, face amount	$ 25,000,000
Debt instrument, term	5 years
Debt instrument, interest rate, stated percentage	6.625%
Amounts of funds accessed in period	$ 23,900,000
Redemption price	100.00%

Notes Payable - Debt Outstandin

Notes Payable - Debt Outstanding (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018	Apr. 26, 2017
Line of Credit Facility [Line Items]
Unamortized issuance costs	$ (577)	$ (745)
Notes payable, net	24,423	24,255
Senior unsecured notes
Line of Credit Facility [Line Items]
Notes payable, outstanding gross of unamortized issuance costs	$ 25,000	$ 25,000
Debt instrument, interest rate, stated percentage			6.625%

Statutory Information (Details)

Statutory Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Statutory Accounting Practices [Line Items]
Statutory net income/loss amount	$ 8,097	$ (49,648)
Statutory capital and surplus, balance	5,496		$ 14,377
Illinois
Statutory Accounting Practices [Line Items]
Statutory capital and surplus required, minimum	1,500
Missouri
Statutory Accounting Practices [Line Items]
Statutory capital and surplus required, minimum	2,400
New York
Statutory Accounting Practices [Line Items]
Statutory capital and surplus required, minimum	$ 3,500

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event $ in Thousands	Jan. 22, 2020USD ($)	Dec. 31, 2019
Subsequent Event [Line Items]
Percent of future sales collected by subsidiary		0.49
Sale of subsidiary	$ 4,700

Uncategorized Items - afh-20190

Label	Element	Value
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 0
AOCI Attributable to Parent [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	(377,000)
Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 377,000